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INTRODUCTION
11. INTRODUCTION
Low Bone Density is a term which comprises the two entities of
osteopenia and osteoporosis. These form a continuum in the disease spectrum
where osteopenia refers to milder bone density loss and osteoporosis to severe
bone density loss. Osteoporosis has been defined as “a systemic skeletal
disease characterised by low bone mass and microarchitectural deterioration
of bone tissue with consequent increase in bone fragility and susceptibility to
fracture”.1
The World Health Organisation (WHO) defines the same as Bone
Mineral Density (BMD) more than 2.5 standard deviation below the peak
BMD of a young reference population. Definition of severe osteoporosis is
BMD more than 2.5 standard deviation below the peak BMD and the
presence of fractures. Osteopenia is the BMD that lies between 1 and 2.5 SD
below the mean value of a young adult.2
Osteoporosis is termed as a “silent disease” and a “silent global
epidemic”. It is called a silent disease as bone density is gradually lost over
time without manifesting any signs or symptoms until a bone densitometry
test reveals bone loss or a fracture occurs with minor trauma. It is called as a
silent epidemic as the disease has been rising in proportions without being
duly recognised by the medical fraternity and without awareness among the
general population.2
3osteoporotic patients. An estimated 25 million people are affected by
osteoporosis alone in India in 2003 and this is expected to rise to 36 million
by 2013.5
The direct cost of treating hip fractures in government hospitals across
the country surgically is around 150 USD or approximately 10,000 rupees
whereas the same at a private hospital is 2500 – 3000 USD or 1,50,000 to
2,00,000 rupees approximately. This places a heavy burden on the people
seeking treatment as majority of the population have to spend out of pocket
and are not covered by insurance and this does not even take into account the
indirect costs incurred.4
21.1 Global Scenario
Osteoporosis afflicts an estimated 200 million people worldwide. An
estimated 75 million people are affected in the United States, Europe and
Japan. Fractures due to osteoporosis are more than 8.9 million annually
worldwide. The lifetime risk of an osteoporotic fracture in developed
countries is 30 – 40% which is close to that of coronary heart disease. It
accounts annually for 2.8 million disability – adjusted life years (DALYs) in
America and Europe that is approximately 1% of the DALYs contributed by
non communicable diseases.3
It is predicted that one in every three women and one in five men will
suffer from an osteoporotic fracture worldwide. The incidence of hip fracture
will increase by 310% in men and by 240% in women by the year 2050.
The belief that osteopenia and osteoporosis are diseases of the west is
turning out to be a myth with many Asian countries showing a 2 – 3 fold
increase in the incidence of hip fractures over the last 3 decades. More than
50% of the osteoporotic hip fractures are expected to take place in Asia by
2050. There is mounting evidence that epidemics of hip fractures are
occurring with the wave of urbanisation through Asia.4
1.2 Indian Scenario
With a large population and the growing ageing populace due to the
increasing life expectancy, India is home to a large number of osteopenic and
OBJECTIVES
42. OBJECTIVES OF THE STUDY
1. To estimate the prevalence of low bone density among individuals
aged 18 years and above in Nanganallur, an urban area of Chennai
in 2012.
2. To estimate the prevalence of associated modifiable risk factors
among the study population.
JUSTIFICATION
53.  JUSTIFICATION
1. WHO terms osteoporosis as a ‘silent epidemic’ and as a ‘silent
disease’.
2. An estimated 25 million people are affected in India. This shows the
high prevalence of the disease.
3. By the time the symptoms manifest the disease is already in an
advanced stage. Early diagnosis offers the advantage of lead time
where the risk factors of the disease can be modified.
4. Low bone density is attributed to several risk factors of which many
are modifiable. This provides scope for modifications of those risk
factors identified.
5. Paucity of community based studies on low bone density in India,
particularly from Tamil Nadu and especially in the urban areas from
among the reviewed literature makes it a necessity to carry out this
study.
Hence, this study was undertaken to estimate the prevalence of low
bone density and its associated risk factors.
REVIEW OF
LITERATURE
64.  REVIEW OF LITERATURE
4.1  LOW BONE DENSITY
Low Bone density comprises of two components, osteopenia and
osteoporosis. It means a generalised decrease in the bone mass. It is noted that
low bone mass and low bone density are terms used interchangeably in the
reviewed literature to denote the combined components of osteoporosis and
osteopenia.6
Osteoporosis was a term coined by Pommer in 1885 to distinguish it
from osteomalacia. He defined osteoporosis as a condition with decreased
skeletal mass associated with increased porosity. Osteoporosis is
characterised by the presence of quantitatively deficient yet qualitatively
normal bone. The histologic and chemical analysis of the bone indicates it is
structurally normal.
Osteoporosis was defined by the 1990 consensus development panel as
“a systemic skeletal disease characterised by low bone mass and
microarchitectural deterioration of the bone tissue with consequent increase in
bone fragility and susceptibility to fractures”.1
The World Health Organisation defines osteopenia and osteoporosis as
follows:
7Table 1: WHO definitions of low bone density based
on BMD measurements7
Definition Bone Mass DensityMeasurement T-Score
Normal BMD within 1 SD of the mean
bone density for young reference
population
T-score more than
or equal to –1
Osteopenia BMD 1–2.5 SD below the young
reference population mean
T-score between
–1 and –2.5
Osteoporosis BMD ?2.5 SD below the normal
for young reference population
mean
T-score less than or
equal to –2.5
Severe
Osteoporosis
BMD ?2.5 SD below the normal
mean for young reference
population  in a patient who has
already experienced ?1 fractures
T-score less than or
equal to –2.5 (with
fragility
fracture[s])
4.2 PREVALENCE OF LOW BONE DENSITY
4.2.1 World
The most common metabolic bone disease seen worldwide is
osteoporosis. Low Bone density is commonly regarded as a disease of old age
and especially the elderly female.  Ross PD had noted that by using the WHO
cut off criteria approximately 15% of young adults have osteopenia and 0.6%
have osteoporosis. In the United States, Ross states that only 1 in 9 women
have normal BMD and 1 in 3 have osteoporosis with the rest having
osteopenia.8
Studies in the Russian Federation estimate that 14 million Russians
have osteoporosis and another 20 million have osteopenia.  In Poland an
estimated 18.5% women older than 55 years suffer from osteoporosis and
40.7% suffer from osteopenia irrespective of their residential status, i.e.,
urban or rural.9
8In studies from Egypt it was seen that among postmenopausal women,
53.9% have osteopenia and 24.8% have osteoporosis. Among men, 21.9% are
found to be osteoporotic and 26% osteopenic.10
4.2.2 Asia
The prevalence of osteoporosis among adult Pakistani women in a
study conducted by Fatima M was seen to be 12.9% whereas the osteopenic
women constituted 43.4% of the 334 women enrolled in the study.11
A study by Li Yin Ming et al among 498 women and 383 men aged 51
years and above, the proportion of women with osteoporosis and osteopenia
was 35.9% and 42% respectively. Among the men, the proportion of
osteoporosis and osteopenia was 17% and 42.6% respectively. Overall, 77.9%
of women and 60.1% of the men were concluded to have low bone mass.12
4.2.3 India
A camp based study conducted by Abraham Samuel Babu et al places
osteoporosis at 42.2% among the 609 persons screened in a rural area of north
Kerala in India and osteopenia at 40.5%.  The males and females both showed
high prevalence rates with 64.7% of males and 85.2% of females being
affected by low bone density.13
Studies by Sharma et al among urban women in Jammu noted that
36.79% of them had osteopenia and 20.25% had osteoporosis. Above the age
9of 65 years it was seen that all women had low bone density with 50% having
osteopenia and the other half having osteoporosis.14
Prasad D V in his study conducted among the health care professionals
of a hospital at Loni observed that among the 264 subjects in the age groups
between 21 – 61 years, osteoporosis was evident in 28.03% whereas
osteopenia was seen in 31.06% of them. Among the males, it was 23.33% of
osteoporosis and 26% of osteopenia and among the females it was 34.12%
and 37.2% respectively.15
Pande KC’s study among healthy Indian population showed that 29.9%
of women and 24.3% of men had low bone mass. This study was conducted
using digital X ray radiogrammametry.16
4.3 FRACTURES DUE TO LOW BONE DENSITY
4.3.1 Incidence of fractures due to low bone density
One of the main complications of extremely low bone density or
osteoporosis is the occurrence of fractures that affect various bones of the
body especially in the elderly. The incidence of fractures is alarmingly high
and is predicted to rise.
Osteoporotic fractures are occurring one every three seconds globally
and over 50 years of age, one in two women and one in five men will suffer a
fracture in their lifetime ahead. By 2050, it has been predicted that the
worldwide incidence of fractures would be around 6.3 million per year and
Asia and Latin America would be harbouring more than half of these.17
10
90% of wrist and hip fractures among the elderly in the United States
are due to non-violent trauma.8
 34 million people in the Russian Federation are at high risk for
fractures with 7 vertebral fractures occurring every minute in those over 50
years of age and one hip fracture occurring every 5 minutes.9
A study by Tuzun et al at Turkey predicts the annual incidence of
osteoporotic fractures at 109 per 1, 00,000 men of age more than 50 years and
226/1, 00,000 women of age more than 50 years for the year 2009.18
Community based studies are lacking in India but based on hospital
studies it can be seen that hip fractures are common here as well. In studies
conducted in India by Sankaran among 1393 patients of 3 Delhi hospitals it
was seen that hip fracture was common among both sexes with the average
age of fractures being 60-70 years.19
A study conducted among expatriate Indians in Singapore showed that
women had higher incidence of hip fractures than men. The Indian population
also showed higher hip fracture incidence i.e. 128 men and 361 women per
1,00,000 population as compared to Malays but this was lesser than the
incidence among the Chinese population. The peak age for the occurrence of
fractures in all of these populations was over 70 years.
Extrapolating these results to the current Indian population, it was
estimated that the number of hip fractures each year would be more than
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4,40,000 with a 3:1 female: male ratio. This criteria puts projections for 2020
at more than 6,00,000 and for 2050 at more than 1 million.20
4.3.2 Socio-economic burden of fractures due to low bone density
One of the main reasons that low bone density must be prevented,
detected and treated is the consequent fractures that occur which in turn place
a huge socio-economic burden on the public health system and on the affected
individuals even in developed countries and more so in a country like India.
In a study conducted at Sweden, the total costs towards the treatment
of a hip fracture works out to approximately 10,00,000 Rupees or 12,200
Euros. The study also reports a poor quality of life among those who had
sustained hip and wrist fractures. The cost of community caring and social
insurance is high following a fracture.21
 For the people treated at a public hospital in India for a hip fracture,
the direct cost borne by the patient for hospital treatment is approximately
10,000 Rupees and for those treated at a private hospital, the costs maybe up
to Rupees 2 lakhs. The public health system pays for the remaining costs
incurred by the individual towards treatment in a government set up. This is in
addition to the burden of lost wages and diminished quality of life of the
affected individual and also an extra burden to care for the patient by the other
family members.4
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4.4 THE SKELETAL SYSTEM
4.4.1 Anatomy of the Skeletal System22
The skeletal system is made of the bony skeleton and the joints
including the cartilage. It provides a rigid frame work which protects and
supports the soft tissues of the body. It also acts as a system of levers and
struts which permit movement of the body through the muscles attached to it.
Bone
The bone is highly vascular mineralised connective tissue which
consists of cells and an intercellular matrix within which the most of the cells
are embedded. The matrix consists of 1.the organic matrix which is formed
mainly of collagen fibres and 2.inorganic salts (which is rich in calcium and
phosphates).
i) Macroscopic Anatomy
The living bone is white in colour and may be either dense in texture or
honey combed in appearance. The former is the cortical or compact bone
found in the cortices of mature bones and it provides strength. The latter is
called cancellous, trabecular or spongy bone. It is formed by a latticework of
bars and plates or trabeculae and is usually present internally. Cancellous
bone provides additional support to the cortex and supports the bone marrow.
Bone forms a reservoir of calcium and phosphate, the content of which
is under hormonal and cytokinal control. The proportions of cortical and
cacellous bone varies depending on whether it is a long or flat bone.
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ii) Microstructure of Bone23
Histologically, bone consists of extracellular mineralised matrix and a
number of various cell types which include osteoclasts, osteoblasts and
osteocytes, the cells of its vascular and nervous supply and the components of
the periosteum, endosteum and the marrow.
a. Bone matrix
It is the extracellular mineralised material of the bone. It consists of the
ground substance in which collagen fibres are embedded in parallel. 10 -20%
of the matrix is made of water. The dry weight of the matrix contains 60-70%
of inorganic mineral salts (hydroxides, hydroxyapatite, microcrystalline
calcium and phosphate), 30-40% of collagen and 5% of non collageonus
protein and carbohydrates mainly glycoproteins.
Before mineralisation, the matrix is called as the osteoid. Adults have
very less osteoid which reflects the local site remodelling of bone in which
mineralisation follows depletion of the organic matrix.
b. Collagen
It is synthesised by the osteoblasts and is mainly type I collagen. It
provides mechanical strength to the bone.
c. Non collagenous organic matrix
It is complex and contains various macromolecules in small amounts
attached to the collagen fibres and to the surrounding bone crystals.
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d. Osteonectin
The osteoblasts secrete this phosphorylated glycoprotein. It binds to
collagen and hydroxyapatite and initiates hydroxyapatite crystallisation.
e. Osteocalcin
Osteocalcin is another glycoprotein synthesised by osteoblasts. It binds
to calcium and hydroxyapatite and it is a marker of new bone formation. It is
required for bone mineralisation.
The matrix also contains proteases, protease inhibitors and many
growth factors secreted by the blasts.
f. TGF – ?
Osteobalsts and osteoclasts secrete TGF –?. It is activated in acidic
conditions of the ruffled border zone of the osteoclast and acts as a coupling
factor for stimulating new bone formation at resorption sites.
g. Bone minerals
These form the inorganic constituents of the bone matrix. It provides
hardness and rigidity to the bone and it is the main reason for the bone being
visible on a radiograph (50% mineralisation of the bone is needed for it to be
visible on a X ray). It is largely composed of crystals made of hydroxyapatite
Ca10(PO4)6(OH2) and a small amount of calcium and phosphate. The major
ions in the matrix are calcium, phosphate, hydroxyl and carbonate. Citrate,
sodium, potassium, magnesium, fluoride, chloride, zinc, copper, aluminium,
lead, strontium, silica and boron are seen in less numerous quantities.
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h. Osteoblasts
Osteoblasts are derived from osteoprogenitor cells and have features of
protein secreting cells. They are seen on the forming surfaces of growing or
remodelling bone where they constitute a monolayer covering. Osteoblasts are
responsible for the synthesis, deposition and the mineralisation of bone matrix
which they secrete. Once they are embedded in the matrix they change into
osteocytes. The major activity of osteocytes is to synthesise and secrete
organic matrix. It secretes other products like osteonectin, osteocalcin,
osteopontin, RANKL (Receptor activator for Nuclear factor ?? ligand),
osteoprotegerin and some other proteoglycans and growth factors like BMPs
(Bone morphogenetic proteins). RANKL is the cell surface ligand for RANK,
an osteoclast progenitor receptor protein.
Osteoblasts play a major role in the mineralisation of the matrix.
Alkaline phosphatase on the osteoblast raises the local concentration of
calcium and phosphate. During bone deposition, osteoblasts via RANKL
binding to RANK on immature clasts regulate the extent of osteoclast activity.
In the presence of the parathyroid hormone, osteoblasts secrete
osteoprotegerin which has higher affinity to RANKL.  This causes the
osteoclasts to mature and resorption occurs.
i. Osteocytes
It is the major cell type of the mature bone. They play a role in the
maintenance of the bone and the death of the osteocytes leads to resorption of
the matrix by osteoclast activity.
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j. Osteoclasts
Osteoclasts are responsible for the local removal of bone during
growth and subsequently during remodelling. Each osteoclast contains a
ruffled border which is the site of local bone resorption. They cause
demineralisation by release of protons which creates an acidic environment by
the release of lysosomal and non-lysosomal enzymes. The cytokines secreted
by the osteoblasts and other cells such as the macrophage stimulates the
osteoclasts.
k. Osteons
The mechanical properties of bone depend on the type of organisation
of the matrix. The organisation may either be of the woven or lamellar type.
Woven bone has collagen and fibres irregularly attached and are commonly
seen in the fetal bones. They are seen in adults during excessive rapid bone
remodelling and repair of fractures. Lamellar bone is seen as lamellae
arranged around neurovascular channels as concentric cylinders (Haversian
canals). They are found in the adult skeleton.
4.4.2 Physiology of Normal Bone
i) Bone Growth and Modelling
During life, bone undergoes radial and longitudinal growth, modelling
and remodelling. During the growth and development in childhood and
adolescence, both radial and longitudinal growth occurs. At the growth plates,
longitudinal growth occurs. Here cartilage proliferates in the metaphyseal and
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epiphyseal areas of the long bones, before subsequently undergoing
mineralization to form new bone.
Modelling is the process by which the overall shape of bones change in
response to the physiologic influences and mechanical forces, leading to the
adjustment of the skeleton gradually to forces that it encounters. There may
be widening of bones or change in axis by the removal or addition of bone to
the appropriate surfaces by the independent action of osteoclasts and
osteoblasts in response to biomechanical forces.
ii) Remodelling
The process by which bone is renewed so as to maintain bone strength
and homeostasis of minerals is called bone remodelling. It involves the
continuous removal of old bone in discrete packets, the replacement of these
packets by newly synthesized proteinaceous matrix and the subsequent
mineralization of this matrix to form new bone. This process of remodelling
resorbs old bone and helps to form new bone so as to prevent any bone micro
damage accumulation.
Remodelling of bone begins even before birth and it continues till
death. The bone remodeling unit (BRU) comprises of a tightly coupled group
of osteoclasts and osteoblasts which sequentially carry out old bone resorption
and new bone formation. Perimenopausal and early postmenopausal women
show an increase in bone remodelling and then slows with aging but
continues at a rate faster than premenopausal women. Aging men have an
increased bone remodeling as well. Infants show a 100% turnover of bone in a
year whereas in adults the bone turnover rate is 18% a year.
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The remodelling cycle comprises of four sequential phases. The four
phases in sequence are activation followed by resorption and reversal and
finally formation.
a. Activation
This occurs 360 times in an hour in a normal adult. The osteoblasts and
haematopoietic precursors initiate osteoclast activation and are sometimes
initiated by inflammatory cells, particularly T cells. Osteoblasts initiate
activation of osteoclasts by production of RANKL, a ligand for the receptor
activator of NF-?? (RANK) leading to the differentiation of osteoclasts and
maintenance of their function. Osteoprotegerin (OPG) also secreted by
osteoblasts, is a decoy receptor that can block RANKL/RANK interactions
and inhibits the activity of osteoclasts.
b. Resorption
On activation, multinucleated osteoclasts are formed by the fusing of
circulating monocytes which degrade the organic and inorganic components
of the matrix by their ruffled border. This creates a cylindrical tunnel by its
concerted action and a ‘cutting cone’ is formed by groups of osteoclasts.
c. Reversal
During the reversal phase, the osteoclasts and resorbing cells die by
apoptosis and are replaced by osteoblasts. These cells track the osteoclasts as
they tunnel through the cortex.
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d. Formation
The initiation of the formation phase is possibly by factors produced
by the osteoclast or by reversal cells or released from the bone matrix. This
phase is quite longer than the first 3 phases and involves progressive waves of
osteoblasts producing bone matrix. The osteoblasts fill the space caused by
the osteoclasts called the ‘closing cone’. These osteoblasts then become flat
lining cells and become embedded in the bone as osteocytes or they undergo
apoptotic death.
4.4.3 Pathogenesis of bone loss24
Remodelling depends on the balance between the removal and
deposition of bone (i.e. balance between the activities of the osteoblasts and
that of the osteoclasts). The normal remodeling process may be summarised
as follows:
Osteoblasts (RANKL) + Monocytes (RANK)/ M-CSF secreted
by monocytic cells
Differentiation of monocytes into osteoclast
Resorption of bone
Osteoprotegerin secreted by osteoblast compete with RANK to bind RANKL
Inhibition of osteoclast activity
Bone formation
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The pathogenesis of bone loss is associated with excess of the above
osteoclastic activity i.e. remodelling. Normal humans gain bone in early life
and then it plateaus. This is followed by loss of bone as people grow older.
When this bone loss is either accelerated or exaggerated, it causes low bone
density or osteopenia and osteoporosis.
A recent study among postmenopausal women showed that
monoclonal antibodies against RANKL produced prolonged inhibition of
bone resorption.25 Another study showed in estrogen deficient early
postmenopausal women that  on the surface of bone marrow cells, RANKL
levels were increased.26
? Role of Estrogen
Estrogen inhibits the secretion of cytokines such as interleukin-1, IL-6
and Tumor Necrosis Factor-? (TNF-?) which foster the development of
osteoclasts and estrogen also stimulates the production of TGF-? which
increases the apoptosis of osteoclasts. Adult women normally have lesser
bone mass than adult men and after menopause these women have an
additional deficiency of estrogen. This causes an increase in the bone loss.
? Calcium, Vitamin D and Parathyroid Hormone
A clinical trial conducted among older individuals who were highly
predisposed to calcium and vitamin D indicated that the supplementation of
both can lead to reversal of secondary hyperparathyroidism, reduction in the
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bone resorption, increase in the bone mass, reduction of fracture rates and
even reduce the frequency of falling. However, in a recent large study it was
seen that calcium and vitamin D supplementation did not bring down the
fracture incidence significantly, maybe because the studied population was
less deficient in vitamin D.27
? Role of prostaglandins and cytokines
The concept that the cytokines produced locally such as IL-1 and
prostaglandins like prostaglandin E2 (PGE2) affecting bones is more than 30
years old. Recently, many cytokines have been found to either stimulate or
inhibit bone resorption and formation. Both stimulatory and inhibitory actions
are displayed by prostaglandins. However, the predominant effect of the
major prostaglandin produced by bone cells (PGE2), is stimulating both
resorption and formation. Prostaglandins, especially PGE2, are produced by
bone cells largely by the action of cyclooxygenase 2 (COX2). It is induced by
many of the factors that stimulate bone resorption and therefore enhance the
response to these agents.28
? Collagen abnormalities
The first intron of the gene coding for type I collagen ?1 chain if
showing a particular polymorphism can influence fracture risk independent of
BMD along with increased levels of homocysteine.29
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4.4.4 Summary of pathogenesis of Low Bone Density
To summarise, the bone remodelling cycle is extremely complex.
Osteocytes, osteoblasts and osteoclasts, the three major cells arising from
different stem cells (mesenchymal for osteoblasts and osteocytes and
hematopoietic for osteoclasts) are controlled by a variety of factors which
harmoniously orchestrate a systematic remodeling sequence. The birth and
death of these cells along with the regulatory factors which control those
events, although complex, are essentially important for understanding the
pathogenesis of osteoporosis. Alterations in any stage of the process of
recruitment, activation, differentiation or cell death can lead to imbalance in
remodelling which would ultimately result in bone loss or reduced bone mass
or density.
4.5 RISK FACTORS FOR LOW BONE DENSITY
Low Bone Density may occur as a result of many complex risk factors
each contributing to increased osteoclastic activity thereby causing increased
bone resorption. The risk factors may either be modifiable or non modifiable.
4.5.1 Modifiable Risk Factors
Low bone density is caused by a myriad of causes working together.
There are proven modifiable risk factors which cause low bone density and
they include the following:
? Alcohol
? Smoking
? Low body mass index
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? Poor nutrition
? Vitamin D deficieny
? Estrogen deficiency
? Caffeine intake
? Insufficient exercise
i) Alcohol
On comparing with individuals who consume alcohol in moderate
amounts and those who do not consume any alcohol, people consuming
alcohol in excess of 2 units a day have a 40% increased risk of sustaining any
osteoporotic fracture. High alcohol intake leads to secondary osteoporosis by
its direct effects on the osteoblasts and on the parathyroid hormone that
regulates calcium metabolism and by also causing poor nutritional status
(protein, calcium and vitamin D deficiency).30
 Use of any alcohol was seen to produce lower bone density among
adolescents than those who did not in a study by Korkor et al.31
A study by Tucker et al among men, premenopausal and
postmenopausal women of the Framingham Offspring cohort showed that
high intake of liquor ( > 2 units per day) was associated with lower bone
mineral density.32
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ii) Smoking
People with history of having ever smoked cigarettes and people who
currently smoke are at increased risk of fractures as compared to non-
smokers.33
Studies by Szuluc indicated that bone density was low among
individuals who either are either current smokers or past smoker.34
iii) Low body weight and body mass index
People with higher values of body mass index also tend to have higher
values of BMD. A positive correlation is seen between body mass index and
bone mineral density. People who have a BMI less than the normal, i.e. BMI<
18.5 kg/m2 are at risk of developing low bone density. Obesity acts as a
protective factor in the development of low bone density.35
A community based study conducted in Sri Lanka by Lekamwasam
among men aged 50 years and above showed that the individuals in the higher
tertile have higher mean body weight than those in the lower two tertiles.36
Funakoshi’s study indicates a very significant positive correlation
between bone density and weight ( r=0.45, p < 0.001) and BMI (r=0.48 , p <
0.001).37
iv) Poor nutrition
The intake of insufficient calcium in diet or its inefficient absorption
leads to the increased production of parathyroid hormone which hikes bone
remodelling causing mobilisation of osteoclasts and thereby reducing bone
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density. For men and women aged 50 years or less, the recommended intake
of dietary calcium is 1,000 mg/day. For those above 50 years, the intake
recommended is 1,200 mg/day.38
The bone calcium content shows positive correlation with bone mass.
People with BMI <23 kg/m2 have lower bone density values than those with
BMI >27 kg/m2. Overweight or obese women, have better calcium absorption
and also lesser post climacteric bone mass loss, than those with normal body
weight. Women who have lower BMI have higher bone fracture risk caused
by lower bone density and lesser subcutaneous fatty tissue. It is acceptable if
older women are to be a little overweight for protection of osteoporosis, as
long as risk factors for diseases like hypertension, type 2 diabetes,
dyslipidaemia and other cardiovascular diseases are absent39.
A randomised controlled trial conducted among healthy
postmenopausal women found that calcium supplementation lowered the rate
of loss of bone density among women who had low levels of calcium intake.
Women who were put on placebos had greater degrees of bone loss.40
A Swedish study demonstrated that those who were in the lowest
quintile of calcium intake had higher numbers of fractures and at an increased
rate as well. The percentage of individuals who are osteoporotic reduced with
the increase in calcium intake.41
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v) Vitamin D deficiency
Vitamin D is essential since it helps in calcium absorption from the
intestines into the blood. It is also is made in our skin with exposure to the
sun’s ultraviolet rays. In many people casual exposure to the sun for at least
10-to-15 minutes a day is usually sufficient. However in the elderly, people
who do not go outdoors food or do so covered completely,  supplemental
sources of vitamin D is of much importance. At least 800 international units
of vitamin D and 1,000 to 1,500 mg of calcium daily can protect against
osteoporosis42.
People who took adequate quantities of milk and calcium rich diets
were seen to have better bone mineral densities as compared to those who
took them in lesser quantities or avoided dairy foods.43
vi) Estrogen deficiency
Estrogen deficiency in women leads to bone loss in a similar fashion
that occurs in post menopausal women. It could also worsen the situation if
occurring in adolescence and early adulthood by preventing the build up of
bone mineral density.
Estrogen supplementation as treatment for low bone density has been
well documented to delay the bone loss among post menopausal and in some
cases even improve the bone density however, its effects maybe attenuated in
the presence of other risk factors for low bone density such as tobacco use and
alcohol consumption.44
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vii) Caffeine intake
Caffeine intake if excessive from sources such as coffee, tea or cola
drinks can cause reduced bone density. Caffeine acts by increasing the
apoptosis by osteoblasts thereby reducing the bone mineralisation.45
A study conducted among middle aged women showed a positive
relation between the intake of caffeine and the risk of hip fracture and the
relative risk of fractures among women in the highest quintile of caffeine
consumption was 2.95.46
viii) Insufficient exercise
People who practice a more sedentary lifestyle are more likely to have
hip fractures than those who are more active. Studies suggest that post
menopausal women who were physically active, i.e at least had moderate
physical activity for at least 30 minutes on most days of the week as per the
WHO recommendations had lesser incidence of falls and fractures.43
Men above 50 years of age who are less physically active have lower
bone densities compared to the men who are highly physically active this
being statistically significant (p= 0.0001) in the study by Lekamwasam.36
4.5.2 Non-modifiable risk factors:
Apart from the above risk factors which can be modified to prevent
low bone density, there are other non modifiable risk factors. The non
modifiable risk factors for low bone density are as follows:
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? Increasing age
? Gender
? Genetic factors
? Late menarche
? Early menopause or hysterectomy with oophorectomy
? Family history of osteoporosis
? Previous fractures
a) Age
Age plays a major role in thinning of bones and occurrence of low
bone density as there is definite decrease in the BMD as age increases. Peak
bone mass is attained close to the age of 30 years and is influenced by the
presence or absence of various risk factors which affect bone mineral
deposition. Thereafter, a reduction in the bone mass occurs and if accelerated
could lead to low bone density at younger ages. Hence, the onus is on
improving the peak bone mass by increasing bone deposition in the formative
years and reducing the rate of bone loss in later years.47
A linear age related decline in the bone density is seen among women
as they were followed from the ages of 21 – 68 with the attainment of peak
bone mass seen at the end of the linear skeletal growth among these women.48
A study among south Indian men from the age of 41 onwards shows a
significant decline in the BMD of the spine and hip as the age progresses.49
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b) Gender
Gender plays a distinctive role as a risk factor for low bone density.
Women are far more predisposed to low bone density than men at all ages.
Women also attain lower peak bone mass than men and also show greater
decline in bone density at later ages this being marked postmenopausaly. The
rates of fracture though are equal for a given BMD for both men and women.
The T scores calculated to assess low bone density are based on the particular
sex and finally give results which maybe compared between sexes.50
c) Genetic factors
Blacks tend to have the highest bone densities among all races.
Caucasian individuals tend to have lower BMD than their black counterparts
at all ages. Asian and Hispanic people have even lesser BMD than their white
counterparts.54, 51
Race also affects estrogen and Vitamin D sensitivity with the Asians
being more estrogen resistant than Caucasians but more Vitamin D
sensitive.52
d) Late menarche and early menopause
Sex hormone deficiency plays a role in the development of low bone
density. Late menarche and early menopause both lead to shorter durations of
exposure to the sex hormones among the females. This impacts the deposition
and resorption of bone as the protective effect of estrogen is lost.53
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Hysterectomy accompanied by oophorectomy also accelerates the rate
of loss of bone density among women.54
e) Family history of osteoporosis
Family history of osteoporosis is a strong predictor of osteoporosis in
an individual. A study conducted among U.S. women, 19.8% of women with
osteoporosis had a family history positive for osteoporosis and this was
significantly and independently associated (OR = 2.35, 1.87 – 2.96). When
more than one relative was affected the association strengthened (OR= 8.48,
4.5 – 15.9).55
A study conducted in California showed that the BMD levels among
individuals whose family members had positive history of osteoporosis was
lower than those who had a negative family history (p<0.02).56
 f) Previous history of fractures
Sustaining fractures is independently a risk factor for the development
of osteoporosis and further fractures. Previous fragility fractures strongly
indicate the investigation of bone mineral density.57
4.5.3 Secondary causes of low bone density58
Low Bone density also occurs due to pathologies which cause
increased osteoclastic activities leading to accelerated bone loss and also
prevent the normal deposition of bone minerals. These maybe classified as
below:
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Table 2: Secondary Causes of Low Bone Density
I. Endocrine disorders II. Rheumatologic disorders
Hyperthyroidism Rheumatoid arthritis
Primary hyperparathyroidism Juvenile polyarticular arthritis
Type 1 diabetes mellitus Ankylosing spondylitis
Cushing's syndrome Systemic lupus erythematosus
Hypogonadism IV. Malignancy
III. Pharmacotherapy Multiple myeloma
Excessive glucocorticoids Leukemia
Anticonvulsants V. Gastrointestinal disease
Intravenous heparin Pernicious anemia
Chronic L-thyroxine replacement Celiac disease
Proton pump inhibitor (PPI) use Gastrectomy, small/large bowel
resection
Antacid over use Inflammatory bowel disease
VI. Chronic obstructive liver
disease
VII. Renal insufficiency or failure
Primary biliary cirrhosis IX. Genetic diseases
VIII. Immobilization Marfan's syndrome
Prolonged bed rest or wheelchair-
bound
Osteogenesis imperfecta
Space flight Sickle cell anemia
 X. Miscellaneous causes Thalassemia
Anorexia nervosa or bulimia Congenital porphyria
Vegetarian diet Glycogen storage diseases
Lactose intolerance Homocystinuria
Prolonged parenteral nutrition  Hypophosphatasia
Pregnancy and lactation Ehlers-Danlos syndrome
XI. Idiopathic causes  Multiple dystrophy
Juvenile osteoporosis Multiple sclerosis
Idiopathic osteoporosis of young
adults
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4.6 SYMPTOMS AND CONSEQUENCES OF LOW BONE DENSITY
Low bone density does not usually cause any symptom. The thinning
of bones often goes unnoticed until a fracture occurs. Sometimes, chronic
back pain which is aggravated by movements may occur as a result of
osteoporosis.8
4.6.1 Osteoporotic Fractures
Mild or moderate trauma that does not affect normal young healthy
adults is sufficient to cause severe fractures among the osteoporotic
individuals especially the elderly. Falls from a standing height or lower are
sufficient to cause serious hip or wrist fractures among them.
Fractures due to low bone density most commonly involve the
following: wrists, femoral neck and vertebral bodies. The metatarsals,
humerus, ribs, toes, leg, pelvis, hand and clavicle are also commonly fractured
due to low bone density.59
4.7 DIAGNOSIS OF LOW BONE DENSITY
4.7.1 Bone density tests
There are various tests to measure bone density and to diagnose low
bone mass. The tests commonly used in clinical practice are:
? DEXA (Dual Energy X-ray Absorptiometry)60,61
Dual energy x-ray absorptiometry (DEXA) otherwise known as bone
densitometry or bone density scanning, an enhanced form of x-ray technology
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is used to measure the bone density. It is the most accurate method of
measuring BMD in all the available methods. It makes use of beams of X-rays
which estimate the hip and spine bone density. X-ray beams pass easily
through weak bones which are less dense. Strong and dense bones allow less
X-rays to pass through them. The amount of X-rays which are blocked by
bone and soft tissue are compared to each other. DEXA can measure as little
as 2% of bone density loss in a year. The DEXA test results are given in the
form of two scores:
T score — The T score value gives the amount of bone a person has
compared to a young adult of the same gender with peak bone mass. This
score can be used to estimate the risk of developing a fracture.
Z score — The Z score value reflects the amount of bone a person has
compared with other people of the same age group and gender. If this score is
unusually low, it indicates the need for further medical tests.
Benefits
? DEXA is a procedure that is simple, quick and non-invasive.
? The radiation from DEXA is extremely small, i.e. one-tenth the
radiation dose of a chest X-ray.
? Of the available methods for bone density testing, DEXA is the most
accurate method available at present for diagnosing low bone density
and it is also considered as an accurate estimator for fracture risk.
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Limitations
? The risk of radiation however small is present in DEXA.
? Pregnant women cannot undergo DEXA.
? Expensive
? DEXA tests are not helpful in following response to treatment.
? QUS (Quantitative Ultrasound)62
In the past, DEXA which is a relatively costly and time consuming
procedure has only been used for screening of osteoporosis. However, now it
is possible to measure bone density with a small and portable ultrasound unit,
the quantitative ultrasound machine designed exclusively for bone density
testing. QUS measures the heel calcaneal bone density. The hip and spine
density measurements from the DEXA are comparable to the heel
measurements derived by QUS. QUS measures the speed of sound and
broadband ultrasound attenuation using high frequency sound waves.
Therefore it analyses the bone density by measuring both how fast sound
travels through the bone, and by how much of that sound reaches the other
side. The results of the QUS are also given in terms of the T score and are
interpreted like the DEXA T score results.
Benefits
? The procedure is completely non-invasive and painless.
? It does not involve the use of radiation
? Inexpensive (lower cost than DEXA)
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? Relatively simple to implement and process
? Portable
Limitations
? QUS has lesser precision than DEXA.
? Compared to DEXA, QUS has limited usefulness for monitoring and
comparing the effect of medications used to treat osteoporosis.
? Subjects classified as osteporotic using this method require further
investigation such as DEXA to confirm the diagnosis.
? Quantitative Computed Tomography (QCT)
Quantitative Computed Tomography can only done in certain
laboratories and needs to be done by following strict protocols. QCT is a type
of CT scan that measures the spine bone density. Peripheral QCT (pQCT), a
form of QCT measures the density of bones in the arms or legs, usually the
wrist. The T scores obtained from QCT are lower than those measured by
DEXA because the QCT measurements decrease more rapidly.
Benefits
? QCT can measure trabecular and cortical bone separately which is
advantageous to monitor treatment.
? It is the only available modality which direct measures the volume of
bone, which can be expressed directly as density.
? Can be performed on a standard hospital CT.
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Limitations
? The reproducibility of QCT is poor in community settings
? Less accurate than DEXA or dual photon absorptiometry
? Relatively high radiation dose involved
? Expensive
? Dual photon absorptiometry (DPA)
DPA uses a radioactive substance to measure the density of bone. It
can measure BMD in the spine and hip. It also uses very low doses of
radiation but scans much slowly than the other methods. 153Gd is a common
radionuclide used which provides dual energy peaks at 44 & 100keV photons
which were counted separately by scintillation detectors. The accuracy of
photon absoprtiometry is affected by inhomogeneity of soft.
Limitations
? Radionuclide decays and has to be replaced regularly
? Long scanning times due to low photon flux (~40 mins)
? Poor spatial resolution.
4.7.2 Other investigations
For those diagnosed with osteoporosis by one of the above methods, an
initial screening laboratory profile should be done. The secondary causes of
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osteoporosis need to be done on an individual basis. Further recommended
investigations for those diagnosed with osteoporosis are as follows:
i) 25 hydroxy vitamin D level
The optimal level of 25 hydroxy vitamin D in blood is ? 30 ng/mL to
maximally suppress parathyroid hormone secretion.  It is important to have it
measured prior to the initiation of any pharmacologic treatment for
osteoporosis so as to ensure that the stores of vitamin D are adequate before
therapy.
ii) Serum calcium
Measurement of serum calcium enables to rule out the presence of
hypocalcemia (malabsorption/vitamin D deficiency) or hypercalcemia
(hyperparathyroidism). This is needed to correct the presence of
hypocalcemia before initiating pharmacologic therapy for osteoporosis.
iii) 24-hour urine calcium excretion
This enables to diagnose malabsorption (e.g. celiac sprue) and vitamin
D deficiency where its vale is low.  It is high in hypercalciuria, a correctable
cause of bone loss.
iv) Serum creatinine
Serum creatinine should be drawn in order to calculate the 24-hour
urine calcium excretion and in order to ensure safety of newer pharmacologic
osteoporosis therapies.
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v) Thyroid stimulating hormone (TSH)
TSH should be measured in patients who are on thyroid hormone
supplementation.
4.7.3 Investigations for secondary causes of osteoporosis
The other more extensive evaluation for secondary causes of
osteoporosis needs to be considered as indicated on an individual basis. This
evaluation may include the following tests:
Table 3: Investigations for secondary osteoporosis
Alkaline phosphatase Liver function tests
Serum Phosphorus Complete blood count
Erythrocyte sedimentation rate /
C-reactive protein (CRP)
Reproductive Hormones - Lutenising
hormone , Follicle stimulating
hormane, testosterone, estradiol
Tissue transglutaminase 24-hour urinary free cortisol
Serum and urine protein
electrophoresis
4.7.4 WHO fracture risk assessment tool (FRAX) questionnaire
In addition to the above investigations, it is necessary to administer the
FRAX questionnaire to the individuals to assess the 10 year probability of
sustaining a fracture. It was developed by WHO and has questions on 10
independent risk factors of osteoporotic fractures. It has 12 questions in all on
age, sex, height, weight, history of previous fracture, fracture in parents,
presence of rheumatoid arthritis, secondary osteoporosis, glucocorticoid use,
alcohol intake, smoking and the bone mineral density.63
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4.8 MANAGEMENT OF LOW BONE DENSITY
All patients with low bone density need not be started on
pharmacologic treatment. People with osteopenia are advised non
pharmacologic interventions to prevent progression to osteoporosis whereas
people with osteoporosis and at high risk of fractures are treated with
medications.
4.8.1 Non – Pharmacologic management
For patients with low bone density but at low risk of fractures, the
following recommendations on life style modification need to be given:
? Body habitus
A healthy body weight must be maintained (BMI between 20 -25
kg/m2). This forms an important intervention for the primary prevention and
management of low bone density in the earlier stages. Counselling about the
same must be given.
? Diet
A balanced diet consisting of dairy products and other foods rich in
calcium should be advised to the patients. Those with low bone density must
be advised to consume a minimum of three portions of milk and dairy
everyday and fish eating on at least one day a week.39
? Calcium
Adequate calcium from food sources and supplements promote the
health of the bones. When dietary sources are not providing enough calcium,
supplements may be used to meet this goal.
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Daily elemental calcium recommended for healthy individuals from diet
and supplement is 1,000 mg for those of 19-50 years and 1,200 -1,500 mg for
those over 50 years.
? Vitamin D
Adequate vitamin D must be taken to support calcium absorption and
bone metabolism. Since there is evidence that even abundant sunlight
exposure cannot be assumed to produce the much needed vitamin D, dietary
and supplementary sources are essential.
? Exercise
Exercise contributes to many short term as well as long term benefits.
People with low bone density must be encouraged to take up exercises for a
lifetime that they will continue to practice and enjoy. Muscle strengthening
exercises are seen to be an integral part of prevention and treatment of
osteoporosis. Exercise produces positive effects in individuals of all ages and
regular physical activity in early life helps to achieve higher levels of peak
bone density.
? Smoking cessation
Smoking cessation counselling must be done at every visit to a patient
with low bone density. Advice on nicotine replacement therapy must be
given.
? Alcohol restriction
Alcohol use must be restricted to no more than two drinks per day.
This limited intake will help to protect the bones and reduce the risk of falls.
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? Prevention of Falls
The vast majority of hip fractures occur after a fall. Preventing falls is
a major strategy in the reduction of fracture risk. Modification of the
environment, personal risk and medication-associated factors can be effective
in preventing falls. In some studies, hip protector pads for frail elderly adults
in addition to vitamin D supplementation has been shown to reduce hip
fractures.64
Treatment for those with osteoporosis and high risk of fracture is with
the following therapies:
4.8.2 Pharmacologic Treatment
The goals of treating low bone density with medications are:
1.   Reducing the risk of fractures
2.  Decreasing bone loss
3.  Preserving or increasing bone strength
4.  Restoring bone turnover to premenopausal levels in
postmenopausal women
For those who have low bone density and are at high risk of sustaining
fractures, pharmacologic treatment needs to be considered as given in table 4.
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Table 4: Pharmacologic treatment of Osteoporosis65
Drug Mechanism of Action Indication Adverse effect
Bisphosphonates
Alendronate
(Oral)
Etidronate (Oral)
Risedronate
(Oral)
Zoledronic Acid
(Injection)
Bind to the surfaces of
the bones and slows
down the resorping
action of the osteoclasts.
It allows the more
effective work by
osteoblasts. Thereby,
they increase the density
of bone and reduce the
risk of fractures of the
vertebra.
-postmenopausal
women with
severe
osteoporosis
-men  with
severe
osteoporosis
-men and
women of any
age who are
under chronic
steroid
medications at
risk of fracture
abdominal pain,
dyspepsia,
nausea,
esophagitis,
esophageal ulcers,
joint/muscle pain,
ocular
inflammation,
osteonecrosis of
the jaw, atypical
femoral fractures
Synthetic
Parathyroid
Hormone
Teriparatide
(sub-cutaneous
injection)
works on the bone
remodelling process so
that new bone is
generated and added
faster to the skeleton
than the old bone being
broken down. This is
brought about by
activating the
osteoblasts.
-postmenopausal
women with
severe
osteoporosis
- men with
hypogonadal
(low
testosterone) or
primary severe
osteoporosis
-persistent and
chronic systemic
glucocorticoid
therapy in men
and women with
high fracture risk
nausea, dizziness,
leg cramps,
transient
hypercalcemia,
syncope
SERMs
(Selective
Estrogen
Receptor
Modulators)
Raloxifene (oral)
Act by mimicking
action of Estrogen on
the bones
- osteoporosis in
postmenopausal
women
Contraindications:
pregnancy,
history of venous
thromboembolic
events
Adverse drug
effects: flushing,
vasomotor
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Drug Mechanism of Action Indication Adverse effect
symptoms,
thromboemolic
events, leg
cramps, flu
syndrome
Hormone
Replacement
Therapy (HRT)
Estrogen/
Estrogen +
Progesterone
(oral/patch)
HRT supplements
hormones that are
reduced following
menopause to the
lowest level required to
prevent loss of bone.
Either estrogen alone or
estrogen and
progesterone in
combination maybe
given.
-osteoporosis in
postmenopausal
women who also
experience
menopausal
symptoms like
night sweats and
hot flashes.
Contraindications:
history of
thromboemboic
events, breast
cancer
 Adverse drug
effects: nausea,
vomiting,
abdominal
discomfort,
thromboembolic
events, breast
tenderness, breast
cancer, skin
irritation on
topical
application
Calcitonin
(Nasal spray)
slows down the work of
the osteoclasts and
hence allows the
osteoblasts to work
more effectively.
-osteoporosis in
postmenopausal
women
- osteoporosis in
non-pregnant
premenopausal
women
-osteoporosis in
men
localized,
transient nasal
reactions
RANK Ligand
Inhibitor
Denosumab (sub-
cutaneous
injection)
anti-resorptive therapy
that inhibits the
development and
activation of osteoclasts
postmenopausal
women with
osteoporosis
Contraindications:
hypocalcemia
Adverse drug
effects:
dermatitis, rashes,
cellulitis eczema,
pancreatitis,
osteonecrosis of
the jaw
METHODS AND
MATERIALS
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5. METHODS AND MATERIALS
5.1 Study design
This study was conducted at the community level as a cross – sectional
study to estimate the prevalence of low bone density and associated
modifiable risk factors among individuals above 18 years of age at
Nanganallur, an urban area of Chennai.
5.2 Study area
The community based study was conducted at Nanganallur of Chennai
Metropolitan Area. The area has a residing population of approximately
86,000. The number of residents above the age of 18 years is around 42,100.
5.3 Study duration
The study was carried out from January 2012 to December 2012. The
period of field study was from July 2012 to September 2012.
5.4 Study population
The study population comprised of males and females aged 18 years
and above in the Nanganallur area. The reason for choosing this population
was that though low bone density i.e., osteopenia and osteoporosis are seen as
diseases of the aged, the risk factors for low bone density are established at a
much earlier age. Individuals within the age group of 18 – 30 years form the
most effective group where interventions for modification of risk factors can
be taken up as peak bone density is formed at around 30 years of age.
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Inclusion criteria
Males and females of age 18 years and above at Nanganallur who were
willing to participate were included as part of the study.
Exclusion criteria
i) Those individuals who are unwilling to participate in the study were
excluded and
ii) Those who are bed-ridden are also excluded as they need to be
mobilized for having their heel bone density measured by the
quantitative ultrasound machine.
5.5 Sample size
Due to the lack of previous community based studies done among
individuals of this age group in the reviewed literature, the sample size was
calculated by assuming 50% prevalence of low bone density.
At 95% C.I., Z alpha = 1.96
p = 50%, q = 50%.
d (allowable error, 14% of 50%) = 7 and
Design effect = 2,
Sample size =  1.96 x 1.96 x 50 x 50 x 2 = 392
                                   7 x 7
Final sample size was worked out to be 405 as 27 clusters were
selected each consisting of 15 individuals.
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5.6 Sampling method
The study was carried out by a two stage sampling method. The first
stage employed a cluster sampling technique followed by the simple random
sampling within each cluster. The electoral list of Nanganallur of Chennai
Corporation area was obtained. Each street was considered as a cluster and
the total number of clusters in Nanganallur was 278. 15 individuals were
chosen from each cluster.
Therefore, total number of clusters = 278
Number of individuals picked from each cluster = 15
Number of clusters picked from the total
number of clusters =  Sample size
       No. of individuals in a cluster
=  392/15
= 26.133 clusters
Therefore, 27 clusters of 15 individuals each was picked resulting in a
final sample size of 405 individuals of age 18 years and above.
The selected clusters were arranged in order and the numbers of
individuals above 18 years in each of the 27 clusters were arranged
alphabetically and they were listed from serial number 1 onwards. By
employing the simple random sampling technique using computer generated
simple random numbers, 15 individuals were selected from each of the 27
clusters.
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Nanganallur
278 clusters (278 streets)
27 clusters
15 individuals from each cluster
405 individuals
In the absence of the individuals selected by simple random sampling
at the time of the field visit, the next person on the list was included to be part
of the study.
5.7 Study Instruments
A semi structured questionnaire, standard weighing scale, stadiometer
and a portable quantitative ultrasound machine were used.
5.7.1 Questionnaire
A pre tested semi structured questionnaire adapted from the
Osteoporosis risk test developed by the International Osteoporosis Foundation
was used.66 The questionnaire was translated into Tamil and again back
translated to English to ensure that the meaning of the message conveyed did
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not vary. The developed questionnaire was pre-tested and modified to suit the
local population. The questionnaire comprised of 2 parts,
1. The socio demographic particulars of the individuals and their family
and
2. History regarding the modifiable risk factors – This part elicited the i)
fracture history in the individual and their family, ii) diet patterns
which contribute to low bone density, iii) physical activity patterns, iv)
history regarding systemic medical disorders and medications, v)
history of alcohol intake and tobacco usage and vi) menstrual history
from females.
The questionnaire was pretested among 35 individuals of age 18 years
and above of the Nanganallur area and based on the observations, necessary
modifications were made. The results from the pre test were not included in
the final analysis.
5.7.2 Measurements
Following the administration of the questionnaire, measurements of
height, weight and the bone mineral density were made among the
participants of the study.
5.7.3 Height measurement
The height was measured using the same portable stadiometer to the
nearest centimetre. The individual was asked to stand erect, looking straight
ahead and the height measured without wearing any shoes or chappals.
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5.7.4 Weight measurement
The weight was measured by the same calibrated portable weighing
scales (Belita®). The individuals were measured to the nearest 100 grams
while wearing light clothes and without footwear.
5.7.5 Bone density measurement67, 68
The bone densities of individuals were measured using the
Quantitative Ultrasound machine. WHO criteria for diagnosis of osteoporosis
and osteopenia using T – score obtained from QUS was used.
The Quantitative Ultrasound by means of its two parameters, the speed
of sound (SOS) and broadband ultrasound attenuation (BUA) also assesses
the bone structure thus providing better correlation with increased fracture
risk. All other investigations for low bone density only give a quantitative
assessment of the bone density. However, the definition for low bone density
also includes the micro architectural deterioration of bone tissue, a qualitative
aspect which is also measured by the QUS. The calibrated QUS machine
(General Electric’s Achilles®) (Annexure VI) was be used to measure the
heel calcaneal bone density. The same machine was used throughout the
study.
The QUS technique has been applied though DEXA is the gold
standard technique available among the non invasive diagnostic procedures.
This is because DEXA is more expensive and has a risk of ionising radiation
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which is absent with QUS. DEXA qualifies as definitive diagnostic test but
QUS is more apt as a screening test.
The heel calcaneal bone density measured using the QUS yields
similar results as the hip bone density measurements measured using DEXA.
The correlation between the bone density measured using QUS and DEXA is
as much as 80-90%.
The Achilles device has a high sensitivity of 96% comparable to that of
the DEXA. However, the specificity of QUS is only 55%. This could result in
a large number of false positives and hence a DEXA would be needed to
confirm the diagnosis in whom low bone density was diagnosed by the QUS
but it can be a very effective tool in ruling out those who do not have the
disease.69
The negative predictive value of QUS has also been studied to be as
high as 90% but DEXA shows a marginally greater negative predictive value
of 94%.70
On comparison of all other modalities of diagnosis, the QUS was
chosen as the investigative screening tool for low bone density as it offers the
advantages of cost, portability and absence of radiation with good precision of
fracture risk prediction. It was also seen to be the most ideal to be employed
in a community setting cost effectively.
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5.8 Data collection and methods
After obtaining permission from the Director, Institute of Community
Medicine and the Dean, Madras Medical College and approval of the
Institutional Ethics Committee, data was collected from the study area.
Prior to the collection of data, the investigator underwent training
under the guidance of a Radiologist on the use of QUS and interpretation of
the data obtained and also under a radiology technician on the operation of the
QUS along with its calibration.
A pilot study was done among 35 individuals of the Nanganallur area
to pretest the questionnaire and necessary modifications were made. The
clusters were chosen by cluster sampling and individuals within the cluster
were picked by simple random sampling. The individuals were contacted by
going to the house of the individual. The informed consent of the participants
were obtained and then they were administered the questionnaire in the local
language at their homes. The bone mineral density was then measured using
the quantitative ultrasound machine by asking the participants to come to the
house of one of the participants where the machine was placed.
The study subject’s heel had ultrasound jelly applied over it and was
then asked to be placed in the machine. The diaphragm of the machine
containing water encased the heels on being started and gave the results of the
test within a minute. The machine was calibrated once in two days by using
GE’s Plexiglas phantom.
52
Following the T score measurement, if osteopenia was detected the
participants were counselled about life style modifications. If osteoporosis
was identified the participants were referred for further DEXA tests and also
advised life style modifications. The study subjects with risk factors were
advised about appropriate modification of the same.
5.9 Analysis Plan
The collected data was entered into a MS excel sheet and analysis was
done using the Statistical Package for Social Sciences software version 20.
The results are expressed as percentages and proportions. Associations have
been done using Chi square tests, Fisher’s exact test, correlation and
regression. A p value of less than 0.05 has been considered to be significant.
5.10 Operational definitions
5.10.1 Socio economic status
The modified Kuppuswamy scale has been used to classify the socio
economic status of the population (Annexure IV).71
5.10.2 Adequate calcium supplementation
The consumption of supplementary calcium at least one once daily for
at least the last 1 month was taken as adequate calcium supplementation.
5.10.3 Adequate milk intake
The intake of 2 or more glasses of milk per day was classified as
adequate milk intake.
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5.10.4 Adequate fish intke
The intake of fish on at least one day of a week was classified as
adequate fish intake.
5.10.5 Adequate ragi intke
 Ragi consumption on at least one day of a week was classified as
adequate ragi intake.
5.10.6 Caffeine units
The total number of caffeine units consumed by an individual was
calculated as one cup of tea equaling 0.5 caffeine units and one cup of coffee
equaling 1 caffeine unit.72
5.10.7 Adequate sun exposure
Exposure to direct sunlight for at least 15 minutes every day is
classified as adequate sun exposure.
5.10.8 Adequate physical activity
Taking up any sort of aerobic exercise like running, jogging,
swimming, bicycling, etc for at least 5 days a week for a minimum of 30
minutes on all those days was taken as adequate physical activity.
5.10.9 Body Mass index
The BMI was calculated as weight in kilograms divided by height in
m2.73
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5.10.10 Osteopenia
T scores less than -1and more than -2.5 by QUS were classified as
osteopenia.7
5.10.11 Osteoporosis
T scores less than or equal to -2.5 were classified as osteoporosis.
5.10.12 Low Bone Density
Osteopenia and osteoporosis combined were classified as low bone
density.
RESULTS
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6. RESULTS
The study has been conducted among 405 individuals of Nanganallur
and their results have been presented below.
6.1 Sociodemographic Profile of the Participants
Table 5: Socio demographic details of the participants
Socio demographic parameter Number Percentage
Age (in years) 18-30 92 22.7
31-45 151 37.3
46-60 131 32.3
> 60 31 7.7
Sex Male 137 33.8
Female 268 66.2
Socio
Economic
status
(Modified
Kuppuswamy
Scale)
Upper 19 4.7
Upper middle 190 46.9
Lower middle 99 24.4
Upper lower 95 23.5
Lower 2 0.5
Religion Hindu 313 77.3
Christian 68 16.8
Muslim 24 5.9
The mean age of the male participants was 45.2 years with a standard
deviation of 14.1 years and the mean age of the female participants was 40.23
years with a standard deviation of 12.7 years. The ages varied from a
minimum of 18 years to a maximum of 83 years.
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6.2 Prevalence of Low Bone Density
Table 6: Prevalence of Osteopenia and Osteoporosis
Bone Density Number Percentage
Normal 189 46.7
Osteopenia 162 40
Osteoporosis 54 13.3
Total 405 100
Figure 1: Prevalence of low bone density
The prevalence of low bone density i.e. osteopenia and osteoporosis
combined is 53.3% (Confidence interval – 48.45% - 58.21%).
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Normal
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Figure 2: Age wise prevalence of low bone density
The trend of osteoporosis is seen to increase with increasing age and
normal bone density has reduced with increasing age.
Figure 3: Sex wise prevalence of low bone density
The proportion of osteoporotics (14.6%) is higher among males
whereas the proportion of osteopenics is higher among females (41.4%).
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Figure 4: Religion wise prevalence of low bone density
Figure 5: Socio economic class wise prevalence of low bone density
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6.3 Prevalence of low bone density risk factors
Table 7: Prevalence of modifiable dietary risk factors
Factor Number Percentage
Calcium
supplementation
Yes 37 9.1
No 368 90.9
Fish Yes 312 77
No 93 23
Ragi Yes 131 32.3
No 274 67.7
Milk Yes 183 45.18
No 222 54.81
Coffee
consumption
Yes 244 60.2
No 161 39.8
Tea consumption Yes 251 62
No 154 38
Only 9.1% of the population had regular calcium supplementation.
23% of the population did not consume any fish and 67.7% of the subjects do
not consume any ragi at all. 54.81% of the participants avoid milk. Coffee and
tea are consumed by 60.2% and 62% of the subjects respectively.
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Figure 6: Prevalence of inadequate calcium supplementation
Only 25 (67.5%) of the 37 participants taking calcium are having it in
adequate amounts.
Figure 7: Prevalence of inadequate fish intake
46.91% of the participants are having fish once or more in a week.
25
380
0
50
100
150
200
250
300
350
400
Adequate Inadequate/Nil intake
Calcium supplementation
Calcium
supplementation
190
215
175
180
185
190
195
200
205
210
215
220
Adequate Inadequate/Nil intake
Fish Intake
Fish Intake
61
Figure 8: Prevalence of inadequate ragi intake
Figure 9: Prevalence of inadequate milk intake
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Figure 10: Intake of total caffeine units
Table 8: Prevalence of other modifiable risk factors
Factor Number Percentage
Daily Sun
Exposure
Yes 319 78.8
No 86 21.2
Physical
Activity
Yes 100 24.7
No 305 75.3
BMI (kg/m2) < 18.5 28 6.9
?  18.5 377 93.1
21.2% of the subjects are not exposed to the sun at least for 15 minutes
each day. Only 24.7% of them engage in any sort of physical activity.
Underweight individuals i.e. with BMI < 18.5 was 6.9%. The mean BMI of
the male participants was 24.99 kg/m2 with standard deviation 4.09 kg/m2 and
the mean BMI of the female participants was 25.21 kg/m2 with standard
deviation 5.31 kg/m2.
216
189
Caffeine Intake
< 2 units
? 2 units
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Figure 11: Prevalence of inadequate physical activity
Among the 100 participants who are engaged in active physical work,
only 27 participants are engaged in adequate amount of activity.
Table 9: Prevalence of tobacco and alcohol use among males
Factor Number Percentage
Current Smokers among males
Yes 29 21.2
No 108 78.8
Ever Smoked among males
Yes 43 31.4
No 94 68.6
Other forms of tobacco among males
Yes 12 8.8
No 125 91.2
Alcohol intake among males
Yes 45 32.8
No 92 67.2
The prevalence of current smoking among the males is  21.2%  and
31.4% of the male subjects are currently smoking or have smoked before.
8.8% of the male subjects are using alternate forms of tobacco and alcohol is
ingested by 32.8% of the males.
Only 1 female participant answered as a current smoker and 3 of them
had ever smoked. 4 of the females consumed other forms of tobacco and 3 of
them consumed alcohol.
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Table 10: Prevalence of non modifiable risk factors
Factor Number Percentage
History of fracture
Yes 54 13.3
No 351 13.3
Fracture in first degree
relatives
Yes 73 18
No 332 82
Among the non modifiable risk factors for low bone density, 13.3% of
the subjects had self-reported history of fracture without heavy impact and
18% had relatives with history of easy fracturing.
Table 11: Prevalence of reproductive non modifiable
risk factors among women
Factor Number Percentage
Late Menarche ( > 16 years)
Yes 37 13.8
No 231 86.2
Menopause or hysterectomy
< 45 years
Yes 45 44.4
No 36 55.6
Of the female participants, 81 women had attained menopause and
among them 44.4% had attained menopause before the age of 45 years. Only
8 (3%) women among the study participants had used or were using
hormones. None of the women who had attained menopause had taken any
hormone replacement therapy (HRT).
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Table 12: Prevalence of drug intake
 Factor Number Percentage
Thyroxine
Yes 24 5.9
No 381 94.1
Steroids
Yes 9 2.2
No 396 97.8
Antacids
Yes 19 4.7
No 386 95.3
Proton pump
inhibitors
Yes 9 2.2
No 396 97.8
5.9% and 2.2% of the subjects had history of chronic thyroxine or
chronic steroid use, respectively. There was only one person taking anti-
psychotics and anti epileptics each.
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6.4 Low Bone Density and Socio-demographic Variables
Table 13: Socio-demographic distribution of low bone density
Variable
Normal Bone
Density (%)
Low Bone
Density (%) Total
Chi
square df
P
value
Age
Groups
 (in
years)
18-30 52 (56.5) 40 (43.5) 92 6.771 3 0.08
31-45 72 (47.7 ) 79 (52.3 ) 151
46 - 60 54 (41.2 ) 77 (58.8 ) 131
> 60 11 (35.5) 20 (64.5) 31
Sex Males 66 (48.2 ) 71 (51.8) 137 0.189 1 0.664
Females 123 (45.9 ) 145 (54.1 ) 268
Religion Hindus 150(47.9) 163 (52.1) 313 0.881 2 0.644
Christians 29 (42.6) 39 (57.4) 68
Muslims 10 (41.7 ) 14 (58.3) 24
Socio
economic
class
Class I
and II  96 (45.9 ) 113 (54.1) 209
0.093 1 0.760
Class III,
IV and V 93 (47.4 ) 103 (52.6 ) 196
Total 189 (46.7 ) 216 (53.3) 405
There is an increasing trend noticed in the prevalence of low bone
density. The difference between the age groups was not statistically
significant. Females (54.1%) have higher prevalence than males (51.8%). The
association between sex of the individual, religious groups and socio
economic classes and presence of low bone density is not statistically
significant.
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6.5 Modifiable risk factors and socio-demographic variables
6.5.1 Fish intake:
Table 14: Age and sex wise distribution of fish intake
Variable
Fish intake Total Chi
square
df P value
>1/week (%) <1/week
(%)
Age
Groups
18-30 40 (43.5) 52 (56.5) 92  11.125 3 0.011
31-45 82 (54.3) 69 (45.7) 151
46-60 61 (46.6) 70 (53.4) 131
> 60 7 (22.6) 24 (77.4) 31
Sex
Males 61 (44.5) 76 (55.5) 137 0.474 1 0.491
Females 129  (48.1) 139 (51.9) 268
Total 190  (46.9) 215 (53.1) 405
Individuals more than 60 years (22.6%)  show the least intake of fish
followed by those between 18-30 years of age (43.5%). A statistically
significant difference was seen between the age groups and fish intake
(p=0.011). 55.5% of males and 51.9% of females are also not consuming fish
at least on one day of the week. No statistical association was seen.
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6.5.2 Ragi Intake:
Table 15: Age and sex wise distribution of ragi intake
Variable
Ragi intake Total Chi
square
df P value
>1/week
(%)
<1/week (%)
Age
Groups
18-30 9 (9.8) 83 (90.2) 92 4.278 3 0.233
31-45 22 (14.6) 129(85.4) 151
46-60 23 (17.6) 108 (82.4) 131
> 60 2 (6.5) 29 (93.5) 31
Sex Males 15 (10.9) 122 (89.1) 137 1.439 1 0.230
Females 41 (15.3) 227 (84.7) 268
Total 56 (13.8) 349 (86.2) 405
All age groups showed a consistently low intake of ragi. Only 10.9%
of males and 15.3% of females consumed ragi on one or more days of a week
No statistical significance was seen between the age groups or gender based
on ragi intake.
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6.5.3 Milk intake:
Table 16: Age and sex wise distribution of milk intake
Variable
Milk intake
Total Chisquare df P value2 or more
cups (%)
? 1 cups
(%)
Age
Groups
18-30 17 (18.5) 75 (81.5) 92 9.049 3 0.029
31-45 13 (8.6) 138 (91.4) 151
46-60 17 (13) 114 (87) 131
> 60 8 (25.8) 23 (74.2) 31
Sex Males 18 (13.1) 119 (86.9) 137 0.034 1 0.853
Females 37 (13.8) 231 (86.2) 268
Total 55 (13.6) 350 (86.4) 405
Individuals in the older age group (>60 years) had higher milk intake
(2 or more cups) than the other age groups. Percentage of milk intake among
males and females was almost equal. Statistical significant difference was
seen between the age groups.
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6.5.4 Caffeine intake:
Table 17: Age and sex wise distribution of caffeine intake
Variable
Caffeine intake
Total Chisquare df P value< 2 caffeine
units (%)
?2 caffeine
units (%)
Age
Groups
18-30 65 (70.7) 27 (29.3) 92 21.162 3 0.000
31-45 81 (53.6) 70 (46.4) 151
46-60 52 (39.7) 79 (60.3) 131
> 60 18 (58.1) 13 (41.9) 31
Sex Males 62 (45.3) 75 (54.7) 137 5.428 1 0.020
Females 154 (57.5) 114 (42.5) 268
Total 216 (53.3) 189 (46.7) 405
A statistically significant difference was noted between the age groups
and sexes in the total caffeine units consumed.
71
6.5.5 Sun exposure:
Table 18: Age and sex wise distribution of sun exposure
Variable
Sun exposure Total Chi
square
df P value
Yes (%) No (%)
Age
Groups
18-30 64 (69.6) 28 (30.4) 92 16.858 3 0.001
31-45 121 (80.1) 30 (19.9) 151
46-60 115 (87.8) 16 (12.2) 131
> 60 19 (61.3) 12 (38.7) 31
Sex Males 115 (83.9) 22 (16.1) 137 3.316 1 0.069
Females 204 (76.1) 64 (23.9) 268
Total 319 (78.8) 86 (21.2) 405
Greater proportion of people in the 18-30 year age group (30.4%) and
more than 60 year age group (38.7%) are not exposed to adequate sunlight
with significant difference seen between the age groups in sunlight exposure.
Greater number of females (23.9%) are unexposed to sun daily for at least 15
minutes.
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6.5.6 Physical activity:
Table 19: Age and sex wise distribution of physical activity
Variable
Physical activity
Total Chisquare df P valueAdequate
(%)
Inadequate
(%)
Age
Groups
18-30 6 (6.5) 86 (93.5) 92 8.091 3 0.044
31-45 4 (2.6) 147 (97.4) 151
46-60 13 (9.9) 118 (90.1) 131
> 60 4 (12.9) 27 (87.1) 31
Sex Males 18 (13.1) 119 (86.9) 137 13.937 1 0.000
Females 9 (3.4) 259 (96.6) 268
Total 27 (6.7) 378 (93.3) 405
Large proportions of people in all age groups are physically inactive
with >60 years age group showing highest level of physical activity (12.9%).
Females were more physically inactive (96.6%) compared to males (86.9%).
There is a statistically significant difference seen between age groups and
sexes for physical activity.
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6.5.7 Body Mass Index:
Table 20: Age and sex wise distribution of low body mass index
Variable
Body mass index (BMI)
Total
Chi
square
df P value?18.5 kg/m2
(%)
<18.5
kg/m2 (%)
Age
Groups
18-30 75 (81.5) 17 (18.5) 92 26.96 3 0.000
31-45 149 (98.7) 2 (1.3) 151
46-60 124 (94.7) 7 (5.3) 131
> 60 29 (93.5) 2 (6.5) 31
Sex Males 128 (93.4) 9 (6.6) 137 0.038 1 0.845
Females 249 (92.9) 19 (7.1) 268
Total 377 (93.1) 28 (6.9) 405
There were more number of underweight people in the younger age
group (18-30years) as compared to the rest of the age groups. This was
significant statistically. There is an increased proportion of females who are
underweight (7.1%) as compared to 6.6% of males.
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Tobacco and Alcohol
As the number of women smoking, taking alcohol or other forms of
tobacco was negligible, analysis of men alone were taken into account for
statistical comparison between the age groups.
6.5.8 Smoking:
Table 21: Age wise distribution of smoking
Age Groups
Smoking Total Chi
square
value
P value
No (%) Yes (%)
18-30 17 (81) 4 (19) 21
2.653* 0.452
31-45 38 (71.7) 15 (28.3) 53
46 -60 38 (82.6) 8 (17.4) 46
>60 15 (88.2) 2 (11.8) 17
Total 108 (78.8) 29 (21.2) 137
*Fisher’s Exact Test
6.5.9 Tobacco usage:
Table 22: Age wise distribution of tobacco use
Age Groups
Tobacco use
Total
Chi
square
value
P value
Yes (%) No (%)
18-30 21 (100) 0 (0) 21
3.636* 0.275
31-45 46 (86.8) 7 (13.2) 53
46-60 43 (93.5) 3 (6.5) 46
>60 15 (88.2) 2 (11.8) 17
Total 125 (91.2) 12 (8.8) 137
*Fisher’s Exact Test
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6.5.10 Alcohol intake:
Table 23: Age wise distribution of alcohol intake
Age Groups
Alcohol intake
Total
Chi square
value (df=3)
P value
No (%) Yes (%)
18-30 16 (76.2) 5 (23.5) 21
8.040 0.043
31-45 28 (52.8) 25 (47.2) 53
46-60 35 (76.1) 11 (23.9) 46
>60 13 (76.5) 4 (23.5) 17
Total 92 (67.2) 45 (32.8) 137
47.2% of males in the 31-45 years age group consume alcohol. A
statistically significant difference is noted among the age groups on
consumption of alcohol.
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6.6 Association between Low bone density and risk factors
Table 24: Low bone density and modifiable dietary risk factors
Variables
Low bone density
Total
Odds
Ratio
(95%
CI)
Chi-
square
value
(df=1)
P valueNo Yes
Number
 (%)
Number
(%)
Milk
intake
?2 cups 28 (50.9) 27 (49.1) 55 1.217
(0.689 –
2.150)
0.460 0.498
? 1 cup 161 (46) 189 (54) 350
Total
caffeine
units
< 2 units 106 (49.1) 110 (50.9) 216 1.231
(0.832 –
1.821)
1.078 0.299
? 2units 83 (43.9) 106 (56.1) 189
Ragi
intake
Adequate 33 (58.9) 23 (41.1) 56 1.775
(1.001-
3.147)
3.926 0.048
Inadequate 156 (44.7) 193 (55.3) 349
Fish intake
Adequate 96 (50.5) 94 (49.5) 190 1.340
(0.905 -
1.983) 2.142
0.143
Inadequate 93 (43.3) 122 (56.7) 215
Total 189 (46.7) 216 (53.3) 405
Among those with low bone density (216, 53.3%), lower intake of
milk, ragi and fish is seen than those having normal bone density. Those
consuming more than 2 caffeine units per day are greater among people with
low bone density (56.1%) than those with normal bone density (43.9%).
Those not consuming ragi on at least one day of a week have 1.775
odds of low bone density than those who consume ragi on at least a single day
of the week. Statistically significant difference is noticed among those
consuming and not consuming ragi on at least a day a week.
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Table 25: Low bone density and other modifiable risk factors
Variables
Low bone density
Total
Odds
Ratio
(95%
CI)
Chi-
square
value
(df=1)
P valueNo Yes
Number
(%)
Number
(%)
Sun
exposure
Yes 153 (48) 166 (52 319 1.280
(0.791 –
2.072)
1.013 0.314
No 36 (41.9) 50 (58.1) 86
Physical
activity
Adequate 17 (63) 10 (37) 27 2.036
(0.909 –
4.563)
3.087 0.079
Inadequate 172 (45.5) 206 (54.4) 378
BMI
(kg/m2)
? 18.5 174 (46.2) 203 (53.8) 377 0.743
(0.344 –
1.604)
0.576 0.448
< 18.5 15 (53.6) 13 (46.4) 28
Current
smoker
No 175 (46.7) 200 (53.3) 375 1 (0.475
-2.107) 0.000 1.000Yes 14 (46.7) 16 (53.3) 30
Ever
smoked
No 170 (47.4) 189 (52.6) 359 1.278
(0.686 –
2.382)
0.600 0.439
Yes 19 (41.30 27 (58.7) 46
Alcohol
intake
No 166 (46.5) 191 (53.5) 357 0.945
(0.517 –
1.727)
0.034 0.853
Yes 23 (47.9) 25 (52.1) 48
Total 189 (46.7) 216 (53.3) 405
Higher prevalence of low bone density was seen among those who had
inadequate sun exposure (58.1%) and inadequate physical activity (54.4%).
No statistically significant difference was seen for low bone density in terms
of sun exposure, physical activity, BMI, alcohol intake, current smoking or
ever smoked status.
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6.7 Correlation and regression
Table 26: Correlation between T score and age
T score
Age Correlation (r) -0.250
P-Value 0.000
Number 405
Figure 12: Scatter Plot – Age versus T score
There is a negative correlation between age and the T score,i.e. decline
in the T score as age advances and this is seen to be statistically significant
(r= -0.250, n = 405, p =0.000).
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Table 27: Correlation between T score and BMI
T score
BMI Correlation 0.152
P-Value 0.002
Number 405
Figure 13: Scatter Plot – BMI versus T score
As the BMI increases an increase in the T score is seen. The positive
correlation seen between the two variables is statistically significant (r=
0.152, n=405, p=0.002).
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Table 28:   Multiple Logistic Regression Analysis
*Reference category
The multiple logistic regression shows that the factors causing low
bone density after controlling for the effect of other variables are increasing
age groups, inadequate ragi intake and inadequate physical activity. The
individuals in the 46-60 year age group have a 2.086 higher odds of
developing low bone density compared to those in the 18-30 year group and
those above 60 years of age have 2.612 higher odds of developing low bone
density. Both the odds are statistically significant.
Those not consuming ragi at all or inadequately have 1.963 times
higher odds of developing low bone density than those consuming it on at
least one day a week. This was significant at the 0.05 level (p=0.025).
Individuals who do not exercise adequately have a 2.343 times higher
odds of developing low bone density compared to those who exercise
adequately and this was statistically significant (p=0.049).
Variable Beta S.E. ofBeta P-Value AdiustedOR
95% C.I. for
EXP(B)
Lower Upper
Age
Group
18-30
years*
31- 45
years 0.383 0.271 0.158 1.467 0.862 2.497
46 – 60
years 0.735 0.283 0.009 2.086 1.198 3.634
> 60 years 0.960 0.443 0.030 2.612 1.096 6.227
Ragi
intake
?1/week*
<1/week 0.675 0.300 0.025 1.963 1.091 3.535
Physical
activity
Adequate*
Inadequate 0.851 0.432 0.049 2.342 1.004 5.464
DISCUSSION
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7. DISCUSSION
The current study is a community based study conducted to estimate
the prevalence of low bone density, i.e. osteopenia and osteoporosis and the
distribution of its various associated modifiable risk factors among the
individuals aged 18 years and above in Nanganallur. The study carries
significance for the public health threat and huge socio economic problem
that osteoporosis and its consequent fractures carry and for the simple
preventive measures that may be instituted at a young age for healthy bones in
later age for the individuals and a sound backbone for the country’s economy
in the future.
The number of study participants was 405 with 137 males (33.8%) and
268 females (66.2%). The mean age of the male study participants was a
slightly higher 45.2 years compared to 40.23 years in the females. The
modified Kuppuswamy scale has been used to classify the socio economic
status of the participants.
7.1 Prevalence of low bone density
The bone density of the participants was measured using the
quantitative ultrasound technique which reported the result as a T score. This
was interpreted by the investigator using the WHO guidelines on low bone
density T scores. The prevalence of low bone density in the study population
was 53.3% with 40% of osteopenia and 13.3% of osteoporosis (Table 6 &
Figure 1). A study by Babu et al in north Kerala showed the prevalence of low
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bone density to be 82.7% with 40.5% of osteopenia and 42.2% of
osteoporosis.13 The high prevalence noted in the latter study could be due to
the and the camp based approach that was used and the higher mean age (52
±12.8 years) of the participants compared to the current study (41.9 ±13.4
years). A study conducted at Loni among the health care professionals
between the ages of 21 – 61 years noted a prevalence of 31.06% of osteopenia
and 28.03% of osteoporosis.15 The higher proportion of low bone density
could be due to the selective picking of health care professionals and
conducting a hospital based study.
The current study shows an increase in the proportion of osteoporotics
(7.6%, 7.2%, 18.32%, 38.7%) with increasing age groups (18-30, 31-45, 46-
60, >60years) and also a decline in the proportion having normal bone density
(56.5%, 47.6%, 41.2%, 35.4%) (Figure 2). This is consistent with expected
pattern of bone density and age. 48 The T scores also show a negative
correlation with age (Table 26 & Figure 12) as seen in other studies.48,49
The current study shows an increased prevalence of  low bone density
among the females (54.1%) compared to the males (51.8%) but the proportion
of osteoporotics is more among the males (14.6%) compared to the females
(12.7%) (Figure 3). This could be due to the higher mean age of the male
participants than the females. In a study by Prasad, 49% of the males 71% of
the females had low bone density.15 The prevalence among males though
somewhat similar among the males shows a wide variation among females.
This may be due to the biased selection of individuals in the study. In Pande’s
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study 24.3% of the men and 29.9% of the women had low bone mass.16 The
current study has employed QUS as a screening tool for low bone density
whereas the latter has employed radiogrammametry which yields fewer false
positive results.
The prevalence of osteopenia is slightly higher among the Muslim
population (45.8%) and the prevalence of osteopenia is slightly higher among
the Christians (16.2%) (Figure 4). The proportion of low bone density among
the various socio economic classes does not seem to vary much except the
100% of the lower class people having osteoporosis but it has to be
interpreted in the light of the observation that only 2 participants from that
class were included in the study (Figure 5).
7.2 Prevalence of risk factors
The prevalence of each of the modifiable risk factor for low bone
density was enumerated. From table 6, the consumption of dietary factors that
contribute to low bone density can be seen. 23% of the population do not
consume fish at all which is a major source of calcium and 67.7% do not
consume any ragi which is also a readily available rich calcium source.74 Milk
is not consumed by 54.81% of the participants. Among the people consuming
fish, ragi or milk, the proportion have them in adequate amounts is again far
lesser (Figures 7, 8 & 9). Studies show that the South Indian diet of healthy
individuals has far lesser calcium than the recommended dietary allowance.75
The avoidance of these rich calcium sources predisposes these participants to
a state of deficiency thereby leading to low bone density. Calcium
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supplementation apart from the diet is essential for Indians who are naturally
having calcium deficient diets. Only 25 (6.1%) of the participants are having
adequate calcium supplementation (Figure 6).
60.2% and 62% of the participants are coffee and tea consumers
respectively. Almost half of the participants (47%) consume more than 2
caffeine units a day (Table 7 & Figure 10) which negatively impacts bone
density through its action on osteoblasts.45
The daily sun exposure for at least 15 minutes was not present among
21.2% of the individuals. Studies show that Indians are lacking Vitamin D in
spite of the abundant sunlight in the country.76 The avoidance of the sun in
this situation perpetuates Vitamin D deficiency leading to inadequate calcium
absorption.
Only 24.7% of the participants engage in some sort of physical activity
but only 6.66% satisfy the criteria of adequate physical activity. Insufficient
exercise has been shown to be a major risk factor for low bone density and
consequent fractures.43
Underweight i.e. BMI <18.5 kg/m2 was seen among 6.9% of the
participants. This has been documented to be a risk factor for developing low
bone density and obesity has been found to be protective of low bone density
in previous studies.35 The mean BMI among the females in this study was also
high in the overweight range (25.21 kg/m2) which may have resulted in the
higher distribution of low bone density in the males.
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The prevalence of smoking currently among the male participants was
21.2% and 31.4% of males were wither currently smoking or had smoked
previously (Table 9). 8.8% of the males were using alternative forms of
tobacco and 32.8% consumed alcohol. Only a handful of females engaged in
these practices in the current study. Almost one – fifth and one –third of the
males are at risk of low bone density due to their smoking and alcoholic
habits respectively.
The prevalence of some of the non modifiable risk factors were also
elucidated in the study. This was done to identify those who were at risk of
developing low bone density and fractures so that they could be educated on
prevention of falls and fractures. 13.3% of the subjects reported at least one
fragility fracture and 18% had a first degree relative who had a fragility
fracture.
Among the women, 13.8% had attained menarche later than 16 years
of age and of the 81 women who had attained menopause or hysterectomy,
44.4% had had it before the age of 45 years putting these women at greater
risk of low bone density due to the loss of the protective effect of estrogen.
Small percentages of people were taking drugs such as thyroxine,
steroids, antacids and proton pump inhibitors. These people need to be
carefully monitored and be advised to use the drugs judiciously and only
when necessary without using them for continuous prolonged periods. Anti
epileptics and anti psychotics were only used by one subject each.
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7.3 Low bone density and socio-demographic variables
Low Bone Density was not significantly associated with age, sex,
religion or socio – economic class in the present study (Table 13). It is proven
that increasing age and the female gender are distinctly associated with the
development of low bone density.47-50The current study has more number of
younger females and smaller number of people in each of the age groups. This
has possibly failed to demonstrate the association between the age groups,
sexes and low bone density. However a significant negative correlation was
seen between age and the T scores of the individuals (r= -0.250, n = 405, p
=0.000) (Table 26). This shows that with increasing age there is a decline in
the T scores that are representative of the bone density values.
7.4 Modifiable risk factors and socio-demographic variables
The association of age and sex with the risk factors was studied using
chi square tests. Fish intake was statistically significant (p=0.011) between the
different age groups with people in the > 60 year and 18-30 year age groups
showing the least intake.  No sex difference was noted in fish intake. No
difference in ragi intake was noticed among the various age groups and the
sexes. All age groups and both sexes are showing a consistently low
consumption of such calcium rich diet.
Milk consumption patterns were significantly different among the
various age groups (p=0.029) but not between sexes.  Elderly above 60 years
had the highest percentage of adequate milk intake (25.8%) showing that
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individuals of lower age groups are avoiding milk. Caffeine consumption was
significant between the age groups (p=0.000) and sexes (p=0.020) showing
highest consumption again among the 46-60 year age group and among the
males.
Significant difference was noticed in the adequacy of sun exposure
among the age groups (p=0.001) but not among the sexes. The elderly have
the highest percentage of non exposure (38.7%) followed by the 18 -30 years
group and hence reflects their lifestyle patterns of staying indoors. Adequate
physical activity is dismally low among all age groups and both sexes but a
significant difference is noted between the age groups (p=0.044) and sexes
(0.000). Elderly are more active and the females are less active. The BMI
shows a significant difference between age groups (p=0.000) as the youngest
age group has a large proportion of individuals who are underweight (18.5%).
Statistically significant difference was observed between age groups
(0.043) in consumption of alcohol among males but not in smoking or
tobacco use.
7.5 Low bone density and modifiable risk factors
Significant association was seen between ragi intake and the presence
of low bone density (p=0.048). No association was noticed between any of the
other dietary factors like milk, caffeine or fish and low bone density. A study
conducted at Japan showed that those who consumed more fish had higher
bone densities than those who consumed none or less.77 The current study
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fails to demonstrate such an association probably because of the numerous
other factors which influence the absorption of calcium from fish and also
because of the genetic differences between the Japanese and the Indians. A
study conducted in Sri Lanka, people with close genetic linkage to Indians
also failed to show any difference between the diet and bone density of
individuals.36
Other modifiable risk factors like sun exposure, physical activity,
smoking status, alcohol intake and BMI also did not show any statistically
significant association with low bone density.  A study by Lekamwasam
shows more physically active people to have significantly higher bone
densities but this association was not brought out by the current study.36 It
may have been possible to bring out such an association had the physical
activity been classified quantitatively rather than as categorically. A study by
Funakoshi showed no relation between lifestyle factors like drinking, smoking
and exercise as in the present study.37
7.6 Correlation and regression
Correlation between the age and the T scores of the individuals showed
a negative correlation and this was extremely significant (r= -0.250, n = 405,
p =0.000) (Table 26 & Figure 12). This reflects that with increasing age, there
is a decline in the T scores which is a proxy for the bone density values. This
correlation is on par with the known trends of bone density and age.
89
The BMI and the T scores of individuals show a positive correlation
that is extremely significant (r= 0.152, n=405, p=0.002). This shows that with
an increase in the BMI, an increase in the T scores are also seen. This is
consistent with the results seen in other studies.37,78
A multiple logistic regression model was created and the variables age
groups, ragi intake and physical activity were seen to be independent risk
factors for the development of low bone density after controlling for the effect
of other variables in the current study (Table 28). The 31-45 year age group
did not show any significant difference in the odds of developing low bone
density but the 46-60 year group and > 60 year group showed 2.086 and 2.612
times higher odds of developing low bone density compared to the 18-30 year
group which was significant.
Inadequate ragi consumption puts individuals at 1.963 times higher
odds of developing low bone density than those consuming it on at least one
day a week. This was significant at the 0.05 level (p=0.025). Inadequate
exercise has 2.343 times higher odds of leading to low bone density compared
to those who get adequate exercise and this was statistically significant
(p=0.049). The sex variable was also included in the model but it did not
show any significance.
The current study shows a high prevalence of low bone density among
all age groups and both sexes. The prevalence of low bone density associated
modifiable risk factors are also very high among the study population
especially among the younger age group which may hinder them attaining
peak bone mass and predisposing them to low bone density in later life.
SUMMARY
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8. SUMMARY
The current study was a cross sectional study carried out among 405
participants of age 18 years and more to assess the prevalence of low bone
density and its associated modifiable risk factors in Nanganallur, an urban
area of Chennai. This
The study was carried out using a pretested semi structured
questionnaire and a quantitative ultrasound machine which measured the
individual’s bone mineral density and reported the result in terms of T scores
which were interpreted using the WHO guidelines.
The key findings of the study were as follows:
? The prevalence of low bone density among the study population
was 53.3% with 40% prevalence of osteopenia and 13.3% of
osteoporosis.
? A rising trend of osteoporosis and declining trend of normal
bone density was seen with advancing age groups though not
significantly. No significant difference was seen in the
distribution of low bone density by sex, religion or socio
economic class.
? The prevalence of modifiable dietary risk factors was high
among the study population. Fish, ragi and milk intake was
inadequate among 53%, 86.17% and 46.41% of the study
participants, respectively. Caffeine in excess of 2 units was
consumed by 46.6% of the participants.
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? Adequate sun exposure was absent in 21.2% of the study
population, adequate exercise was lacking in a staggering
93.3% of the study population and 6.9% of them were
underweight.
? Alcohol was consumed by almost one third of the male study
population and smoking was practiced by approximately one
fifth of them.
? There was significant difference noted between the various age
groups in consumption of fish, milk and caffeine. The age
groups also showed significant difference for sun exposure,
adequate exercise and BMI. Among the male participants
significant age group differences was noted for alcohol intake.
? Significant sex differences in the risk factors were noticed for
caffeine intake with males having higher intake and for exercise
with females showing lesser physical activity.
? Low bone density was significantly associated with inadequate
ragi intake before adjustment.
? A significant negative correlation was seen between age and the
T scores showing that with age, the bone density decreases.
92
? A significant positive correlation was seen between BMI and
the T score reflecting that with increase in the BMI, increase in
the T scores is seen.
? Multiple logistic regression showed ragi intake, exercise and
age to be independent risk factors for low bone density after
controlling for other variables but sex was not seen to be a risk
factor in the current study.
The study therefore highlights the high prevalence of hitherto
undetected low bone density and the importance of catching them young for
modification of risk factors so as to enable individuals to attain their
maximum possible bone mass, reduce rate of later life bone loss and
incidence of fractures.
LIMITATIONS
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9. LIMITATIONS
1.  The present study has used quantitative ultrasound as the tool for
identifying individuals with low bone density which has lower
precision than DEXA, the ideal diagnostic tool. This may have lead to
some misclassifications.
2.  Certain risk factors like alcohol intake and smoking which have a dose
effect on low bone density have not been quantified by the amount
consumed and hence have restricted value in being predicted as a risk
factor in the current study.
3.  Dietary habits have been used as a proxy for assessing an individual’s
calcium status in place of blood tests.
4.  The study carries the inherent limitations of cross sectional studies,
thereby disabling the understanding of true temporal relationships
between the risk factors and low bone density.
5.  The study has covered a very selective area due to resource constraints
and hence limits the generalisabilty to other urban areas.
RECOMMENDATIONS
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10. RECOMMENDATIONS
Based on the findings of the current study, the following
recommendations are being put forward.
1.  Low bone density, considered to be a disease of the aged has been
silently ravaging all ages and both sexes of the community with an
alarming prevalence of 53.3% in the study. This calls for screening
programmes for those at high risk on account of the huge social and
economic burden it places on the community and country and the
adverse impact on the quality of lives of the affected individuals.
2.  As low bone density has many risk factors which are amenable to
modification, emphasis must be laid on the lifestyle factors like diet,
physical activity, smoking cessation and alcohol restriction.
3.  Health education interventions for building up of high peak bone mass
so as to avoid development of low bone density must be specifically
targeted at the younger age groups as they have contributed to the
major proportion of people with risk factors in the current study.
4.  Further longitudinal studies need to be taken upon the younger
individuals to assess the effect of these risk factors on bone density.
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ANNEXURES
ANNEXURE I
PATIENT INFORMATION SHEET - ENGLISH
Title of the dissertation:
A Descriptive Study on the Prevalence of Low Bone Density and
Associated Modifiable Risk Factors among individuals aged 18 years and
above in Nanganallur, an Urban area of Chennai in 2012.
Presence of Low Bone Density leads to fractures more easily. It has risk
factors which if identified early can modified.
This study is an attempt to identify the magnitude of low bone density and
associated risk factors among those above 18 years of age in Nanganallur.
The privacy of the patients in the research will be maintained throughout the
study. In the event of any publication or presentation resulting from the
research, no personally identifiable information will be shared.
Taking part in this study is voluntary. You are free to decide whether to
participate in this study or to withdraw at any time; your decision will not
result in any loss of benefits to which you are otherwise entitled.
 The results of the special study may be intimated to you at the end of the
study period or during the study if anything is found abnormal which may aid
in the management or treatment.

ANNEXURE II
INFORMED CONSENT FORM - ENGLISH
Title of the dissertation:
A Descriptive Study on the Prevalence of Low Bone Density and
Associated Modifiable Risk Factors among individuals aged 18 years and
above in Nanganallur, an Urban area of Chennai in 2012.
Name of the participant:
Participant ID:
Age  :
(1) I have been explained in detail about the study and its procedure. I
confirm that I had completely understood the study and have had the
opportunity to ask questions.
(2) I understand that my participation in the study is voluntary and that I
am free to withdraw at any time, without giving any reason, without
my medical care or legal rights being affected.
(3) I understand that the principal investigator, others working on the
investigator’s behalf, the Ethics Committee and the regulatory
authorities will not need my permission to look at my health records
both in respect of the current study and any further research that may
be conducted in relation to it, even if I withdraw from the trial. I agree
to this access. However I understand that my identity will not be
revealed in any information released to third parties or published.
(4) I agree not to restrict the use of any data or results that arise from this
study provided such a use is only for scientific purpose(s).
(5) I agree to take part in the above study.
Signature of investigator                                            Signature of participant
Date:

ANNEXURE III
QUESTIONNAIRE - ENGLISH
ID No:
Descriptive Study on Prevalence of Low Bone Density and modifiable
risk factors among individuals aged 18 years and above in Nanganallur,
an urban area in Chennai in 2012
Socio-demographic particulars:
1. Name ..............................................................
2. Age ...........   years
3. Sex ?  Male ? Female
4. Religion ? Hindu ? Christian ? Muslim
5. Address Door No: ............Street: ...................................................
Area: ...............................……..........................................
Pin code: ............................................................................
6. Education of Head of Family
a. ? Illiterate b. ? Primary School   c. ? Middle School
d. ? Higher Secondary e.? Diploma f. ? Graduate
g.? Postgraduate
7. Occupation  of Head of Family …………………………..
a.? Not working b. ? Unskilled c. ? Semi skilled
d. ? Skilled manual  e.? Skilled non manual
f.? Semi professional g.? Professional
8. Family Income: .................. / month
9. Socio economic status: ....................................................
History regarding osteoporosis:
10. Have you ever had a fracture? ? Yes ? No
11. Have any of your first degree relatives (parents/ siblings/ children) ever
had a fracture? ? Yes ? No
12. How many cups of milk do you take in a day?   _________________
cups
13. (i) Do you drink coffee? ? Yes ? No
(ii) If yes, how many cups in a day? _________________________
cups
(iii) Do you drink tea? ? Yes ? No
(iv) If yes, how many cups in a day? _________________________
cups
14. (i) Do you regularly take calcium supplements? ? Yes ? No
(ii) How long have you been taking them? ...................
(iii) How frequently do you take them? ........................
15. (i) Do you consume ragi? ? Yes ? No
(ii) If yes, how frequently?
a.? > 5 times/week  b. ? <5times/Week
c.? Once in two weeks  d.? once a month
16. (i) Do you consume fish? ? Yes ? No
(ii) If yes, how frequently?
a.? > 5 times/week b. ? 1 - 5times/Week
c.? Once in two weeks d.? once a month
17. Are you exposed to the sun for at least 15 mins everyday?
? Yes ? No
18.  i) Do you exercise? ? Yes ? No
ii) If yes, what kind of exercise?
a.? Brisk walking b.? Running / Jogging
c.? Skipping   d. ? Bicycling
e.? Swimming      f.? Aerobics   g.? Lifting weights
iii) How often do you exercise?
a.? < once a week  b.? 1 to 4 days a week    c.? > 5 days/week
iv) How long do you exercise?
a.? < 15 min   b.? 15-30 min   c.? 30min to 1 hr       d.? > 1hr.
19.  (i) Do you have any systemic medical disorders? ? Yes ? No
(ii) If yes, specify..............................................
20. Do you take any of the following drugs?
a. Steroids ? Yes ? No
b. Thyroxine ? Yes ? No
c. Proton pump inhibitors ? Yes ? No
d. Antacids ? Yes ? No
e. Anti epileptics ? Yes ? No
f. Anti psychotics ? Yes ? No
21. Do you smoke? ? Yes ? No
22. Have you ever smoked? ? Yes ? No
23. Do you use any tobacco
products? ?  Yes ? No
24. Do you consume alcohol? ? Yes ? No
If female,
25. At what age did you attain menarche?
a.? <10 yrs  b.? 10-12yrs c.? 13–15yrs d.? 16yrs and
above
26. (i) Have you attained menopause? ? Yes ? No
(ii) If yes, at what age? ............... years
27. (i)Have you had your uterus and ovaries removed (Hysterectomy)?
? Yes ? No
(ii) If yes, at what age? ............... years
28. Have you ever taken any hormones (estrogen / progesterone /
combination)?
? Yes ? No
Examination
29. Height (cm):
30. Weight (kg):
31. T – score (QUS):



ANNEXURE IV
MODIFIED KUPPUSWAMY’S SOCIO ECONOMIC SCALE
Education of head of the family Score
Professional or Honours 7
Graduate or Post-Graduate 6
Intermediate or Post-High-School Diploma 5
High School Certificate 4
Middle School Certificate 3
Primary School or Literate 2
Illiterate 1
Occupation
Professional 10
Semi-Professional 6
Skilled manual worker 5
Skilled non manual worker 4
Semi-skilled worker 3
Unskilled worker 2
Unemployed 1
Family Income per month (in Rs.)
=30375 12
15188-30374 10
11361 – 15187 6
7594 – 11361 4
4556 – 7593 3
1521 – 4555 2
=1520 1
Total Score Class Description
26-29 I Upper class
16-25 II Upper middle
11-15 III Lower middle
5-10 IV Upper lower
<5 V Lower
ANNEXURE V
STUDY AREA MAP
MAP OF TAMIL NADU
MAP OF CHENNAI ZONES                         MAP OF NANGANALLUR
ANNEXURE VI
QUANTITATIVE ULTRASOUND MACHINE
ANNEXURE VII
LIST OF CLUSTERS IN NANGANALLUR
Cluste
r population cummulative frequency cluster population cummulative frequency cluster population cummulative frequency cluster population cummulative frequency
1 135 135 76 88 11508 151 83 25541 226 210 35349
2 159 294 77 393 11901 152 513 26054 227 160 35509
3 183 477 78 239 12140 153 656 26710 228 182 35691
4 311 788 79 113 12253 154 86 26796 229 56 35747
5 82 870 80 90 12343 155 73 26869 230 34 35781
6 209 1079 81 373 12716 156 39 26908 231 137 35918
7 139 1218 82 258 12974 157 321 27229 232 118 36036
8 184 1402 83 86 13060 158 453 27682 233 117 36153
9 69 1471 84 47 13107 159 157 27839 234 263 36416
10 74 1545 85 69 13176 160 67 27906 235 271 36687
11 173 1718 86 92 13268 161 54 27960 236 409 37096
12 234 1952 87 318 13586 162 216 28176 237 85 37181
13 61 2013 88 639 14225 163 89 28265 238 47 37228
14 112 2125 89 77 14302 164 60 28325 239 97 37325
15 268 2393 90 453 14755 165 41 28366 240 63 37388
16 107 2500 91 63 14818 166 75 28441 241 71 37459
17 76 2576 92 51 14869 167 38 28479 242 32 37491
18 119 2695 93 38 14907 168 183 28662 243 321 37812
19 43 2738 94 138 15045 169 59 28721 244 72 37884
20 57 2795 95 212 15257 170 139 28860 245 61 37945
21 82 2877 96 233 15490 171 177 29037 246 45 37990
22 124 3001 97 128 15618 172 323 29360 247 317 38307
23 51 3052 98 230 15848 173 294 29654 248 69 38376
24 68 3120 99 83 15931 174 47 29701 249 141 38517
25 93 3213 100 139 16070 175 52 29753 250 48 38565
26 167 3380 101 202 16272 176 136 29889 251 43 38608
27 98 3478 102 46 16318 177 136 30025 252 103 38711
28 49 3527 103 52 16370 178 42 30067 253 38 38749
29 67 3594 104 264 16634 179 73 30140 254 84 38833
30 136 3730 105 149 16783 180 81 30221 255 57 38890
31 61 3791 106 363 17146 181 163 30384 256 26 38916
32 75 3866 107 84 17230 182 90 30474 257 128 39044
33 352 4218 108 117 17347 183 42 30516 258 107 39151
34 531 4749 109 57 17404 184 44 30560 259 211 39362
35 172 4921 110 62 17466 185 278 30838 260 73 39435
36 69 4990 111 136 17602 186 161 30999 261 95 39530
37 526 5516 112 75 17677 187 176 31175 262 81 39611
38 107 5623 113 124 17801 188 71 31246 263 432 40043
39 56 5679 114 381 18182 189 59 31305 264 194 40237
40 567 6246 115 217 18399 190 80 31385 265 27 40264
41 38 6284 116 76 18475 191 67 31452 266 187 40451
42 81 6365 117 91 18566 192 123 31575 267 254 40705
43 183 6548 118 465 19031 193 123 31698 268 82 40787
44 51 6599 119 268 19299 194 101 31799 269 64 40851
45 43 6642 120 174 19473 195 112 31911 270 57 40908
46 677 7319 121 54 19527 196 48 31959 271 31 40939
47 353 7672 122 33 19560 197 33 31992 272 433 41372
48 63 7735 123 283 19843 198 96 32088 273 129 41501
49 159 7894 124 452 20295 199 79 32167 274 115 41616
50 96 7990 125 162 20457 200 83 32250 275 43 41659
51 142 8132 126 76 20533 201 267 32517 276 139 41798
52 84 8216 127 391 20924 202 88 32605 277 72 41870
53 108 8324 128 215 21139 203 37 32642 278 256 42126
54 234 8558 129 48 21187 204 281 32923
55 94 8652 130 32 21219 205 65 32988 1 st random number = 767
56 42 8694 131 261 21480 206 104 33092 sampling interval = 1560
57 89 8783 132 54 21534 207 72 33164 selected cluster are given in bold
58 165 8948 133 576 22110 208 69 33233
59 39 8987 134 773 22883 209 72 33305
60 312 9299 135 319 23202 210 98 33403
61 78 9377 136 68 23270 211 173 33576
62 121 9498 137 281 23551 212 135 33711
63 63 9561 138 137 23688 213 121 33832
64 138 9699 139 126 23814 214 63 33895
65 273 9972 140 283 24097 215 142 34037
66 47 10019 141 64 24161 216 133 34170
67 65 10084 142 29 24190 217 76 34246
68 86 10170 143 56 24246 218 30 34276
69 301 10471 144 132 24378 219 172 34448
70 72 10543 145 197 24575 220 258 34706
71 51 10594 146 162 24737 221 48 34754
72 63 10657 147 234 24971 222 206 34960
73 38 10695 148 412 25383 223 38 34998
74 411 11106 149 32 25415 224 57 35055
75 314 11420 150 43 25458 225 84 35139
ANNEXURE VIII
KEY TO MASTER CHART
Variable Label Coding
ID No Participant ID 1,2,etc
Age Age of the participant 18,19,20......... years
Sex Sex 0=Male      1=Female
Religion Religion 0=Hindu    1=Christian
2=Muslim
Edn Education of head of the family 1=illiterate
2=primary school
3=middle school
4=higher secondary
5=diploma
6=graduate
7=postgraduate
Occ Occupation of head of the family 1=unemployed
2=unskilled
3=semi-skilled
4=skilled manual
5=skilled non-manual
6=semi-professional
7=professional
Income Total income of the family In Rupees
fractureH Previous history of fracture 1=Yes       0=No
familyH Family history of fracture 1=Yes       0=No
milk Milk intake 0,1,2....... cups
coffee Coffee consumption 1=Yes       0=No
coffeecups Cups of coffee consumed 0,1,2....... cups
tea Tea consumption 1=Yes       0=No
teacups Cups of tea consumed 0,1,2....... cups
Calcium Calcium supplementation y=Yes       n=No
Caldur Duration of calcium supplementation In months/years
Calfreq Frequency of calcium
supplementation
In days
Ragi Ragi consumption y=Yes       n=No
ragifreq Frequency of ragi consumption a=>5times/week
b=<5times/week
c=once in 2weeks
d=once a month
fish Fish consumption y=Yes       n=No
fishfreq Frequency of fish consumption a=>5times/week
b=<5times/week
c=once in 2weeks
d=once a month
exercise Physical activity 0=Yes       1=No
exerkind Type of exercise a=brisk walking
b=running/jogging
c=skipping
d=bicycling
e=swimming
f=aerobics
g=lifting weights
exerfreq Frequency of exercise a=<1/week
b=1-4days/week
c=>5days/week
exerdur Exercise duration a=<15minutes
b=15-30minutes
c=30minutes to 1hour
d=>1 hour
Sun Exposure to sun 0=Yes      1=No
steroid steroid intake 0=No       1=Yes
thyroxine Thyroxine intake 0=No       1=Yes
PPI Proton pump inhibitor use 0=No       1=Yes
Antacid Antacid use 0=No       1=Yes
antiepi Antiepileptic use 0=No       1=Yes
antipsy Antipsychotic use 0=No       1=Yes
currsmok Currently smoking 0=No       1=Yes
eversmok Ever smoked 0=No       1=Yes
tobacco Tobacco use 0=No       1=Yes
alc Alcohol use 0=No       1=Yes
menarche Age of menarche 0= ?16 years
1= >16years
menopause Menopausal status n=No       y=Yes
menoage Age at attaining menopause In years
hys Hysterectomy done n=No       y=Yes
hysage Age at hysterectomy In years
hormone Hormone pills intake n=No       y=Yes
Ht Height of the individual In cm
Wt Weight of the individual In kg
tscore T score of the individual
ANNEXURE IX
MASTER CHART
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